<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">103844</article-id><article-id pub-id-type="doi">10.7554/eLife.103844</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jeong</surname><given-names>Yaeram</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>Chung-ha O</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Muscarella</surname><given-names>Aaron M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Navarro</surname><given-names>Hector H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Deshpande</surname><given-names>Viraj</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Moore</surname><given-names>Lucy G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Keun-Young</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ellisman</surname><given-names>Mark H</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Marsh-Armstrong</surname><given-names>Nicholas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7843-6651</contrib-id><email>nmarsharmstrong@ucdavis.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>Department of Ophthalmology and Vision Science, University of California Davis School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Davis</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Neurosciences Program, Stanford University</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0168r3w48</institution-id><institution>National Center for Microscopy and Imaging Research, Center for Research in Biological Systems, Department of Neurosciences, University of California San Diego School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">San Diego</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bernstein</surname><given-names>Audrey M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040kfrw16</institution-id><institution>State University of New York Upstate Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Syracuse</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Smith</surname><given-names>Lois EH</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00dvg7y05</institution-id><institution>Boston Children's Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>12</day><month>08</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e103844</elocation-id><history><date date-type="received" iso-8601-date="2024-10-14"><day>14</day><month>10</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-12-10"><day>10</day><month>12</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2023-05-30"><day>30</day><month>05</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.05.26.542507"/></event></pub-history><permissions><copyright-statement>© 2025, Jeong et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Jeong et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-103844-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-103844-figures-v2.pdf"/><abstract><p>We previously described a process whereby mitochondria shed by retinal ganglion cell (RGC) axons are transferred to and degraded by surrounding astrocytes in the optic nerve head of mice. Since the mitophagy receptor Optineurin (OPTN) is one of few large-effect glaucoma genes and axonal damage occurs at the optic nerve head in glaucoma, here we explored whether OPTN mutations perturb the transcellular degradation of mitochondria. Live imaging of <italic>Xenopus laevis</italic> optic nerves revealed that diverse human mutant but not wild-type OPTN increase stationary mitochondria and mitophagy machinery and their co-localization within, and in the case of the glaucoma-associated OPTN mutations also outside of, RGC axons. These extra-axonal mitochondria are degraded by astrocytes. Our studies demonstrate that expression of OPTN carrying a glaucoma-associated mutation results in increased transcellular degradation of axonal mitochondria.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>exopher</kwd><kwd>mitophagy</kwd><kwd>astrocyte</kwd><kwd>retinal ganglion cell</kwd><kwd>glaucoma</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Xenopus</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000053</institution-id><institution>National Eye Institute</institution></institution-wrap></funding-source><award-id>EY026471</award-id><principal-award-recipient><name><surname>Marsh-Armstrong</surname><given-names>Nicholas</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000053</institution-id><institution>National Eye Institute</institution></institution-wrap></funding-source><award-id>EY029087</award-id><principal-award-recipient><name><surname>Marsh-Armstrong</surname><given-names>Nicholas</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000053</institution-id><institution>National Eye Institute</institution></institution-wrap></funding-source><award-id>P30-EY012576</award-id><principal-award-recipient><name><surname>Marsh-Armstrong</surname><given-names>Nicholas</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U24 NS120055</award-id><principal-award-recipient><name><surname>Marsh-Armstrong</surname><given-names>Nicholas</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>ISI0OD021784</award-id><principal-award-recipient><name><surname>Marsh-Armstrong</surname><given-names>Nicholas</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM82949</award-id><principal-award-recipient><name><surname>Marsh-Armstrong</surname><given-names>Nicholas</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>2014862-UTA20-000</award-id><principal-award-recipient><name><surname>Marsh-Armstrong</surname><given-names>Nicholas</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32GM 153586</award-id><principal-award-recipient><name><surname>Navarro</surname><given-names>Hector H</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32GM13574</award-id><principal-award-recipient><name><surname>Navarro</surname><given-names>Hector H</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Increased transfer of axonal mitochondria to optic nerve astrocytes after expression of glaucoma-associated Optineurin variants suggest that increased transcellular degradation of axonal mitochondria may play a causative role in at least some forms of glaucoma.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Mitochondria carry out diverse functions including being the major source of energy production (<xref ref-type="bibr" rid="bib4">Attwell and Laughlin, 2001</xref>), and thus the proper quality control of mitochondria is essential for viability (<xref ref-type="bibr" rid="bib10">Chen and Chan, 2009</xref>; <xref ref-type="bibr" rid="bib79">Schon and Przedborski, 2011</xref>; <xref ref-type="bibr" rid="bib77">Rugarli and Langer, 2012</xref>). Mitophagy entails either the constitutive or induced degradation of damaged or unnecessary mitochondria using highly conserved autophagic pathways that are also used to degrade other organelles, aggregates, and pathogens (<xref ref-type="bibr" rid="bib2">Ashrafi and Schwarz, 2013</xref>; <xref ref-type="bibr" rid="bib19">Ding and Yin, 2012</xref>; <xref ref-type="bibr" rid="bib103">Youle and Narendra, 2011</xref>). Mitochondria are often targeted for degradation by a process regulated by a sequence of phosphorylation and ubiquitination steps regulated by two genes that have been linked to Parkinson’s disease, PTEN-induced putative kinase 1 (PINK1) and Parkin (<xref ref-type="bibr" rid="bib37">Kitada et al., 1998</xref>; <xref ref-type="bibr" rid="bib66">Narendra et al., 2008</xref>). Optineurin (OPTN) is one of the principal mitophagy receptors that recognizes these ubiquitinated mitochondria (<xref ref-type="bibr" rid="bib100">Wong and Holzbaur, 2014a</xref>; <xref ref-type="bibr" rid="bib28">Heo et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Lazarou et al., 2015</xref>), others being Nuclear dot protein 52 kDa (NDP52), neighbor of BRCA1 gene 1 (NBR1) and Sequestosome-1 (SQSTM1 or p62) (<xref ref-type="bibr" rid="bib76">Rogov et al., 2014</xref>). Once OPTN is recruited to the ubiquitinated mitochondria, these mitochondria can then associate with microtubule-associated protein 1A/1B-light chain 3 (LC3) on nascent autophagosomes through the LC3 interacting region of OPTN, leading to full engulfment of the tagged organelles inside of the autophagosomes, followed by lysosomal fusion that enables the subsequent degradation of the contained mitochondria (<xref ref-type="bibr" rid="bib88">Stolz et al., 2014</xref>).</p><p>Although mitochondria are primarily produced and degraded in or near the cell soma (<xref ref-type="bibr" rid="bib8">Burke et al., 1988</xref>; <xref ref-type="bibr" rid="bib78">Saxton and Hollenbeck, 2012</xref>), many neuronal mitochondria also reside in distal processes far from the cell body (<xref ref-type="bibr" rid="bib65">Nafstad and Blackstad, 1966</xref>), a situation that is the most extreme in the axons of long projection neurons such as retinal ganglion cells (RGCs) (<xref ref-type="bibr" rid="bib104">Yu et al., 2013</xref>). To date, most studies have focused on mitochondria quality control mechanisms in the soma of cells, and much less is known about mitochondria quality control in axons. Since effective clearance of damaged organelles in long axons is likely essential for their proper function, it has been a long-standing question whether adequate mitochondria quality control, more specifically efficient removal of dysfunctional mitochondria, can occur at these long processes (<xref ref-type="bibr" rid="bib49">Lu, 2014</xref>). There are studies that showed that distal axonal damaged mitochondria, or alternatively damaged parts of mitochondria that undergo fission from the rest of the mitochondria, are transported retrogradely for either lysosomal degradation, or alternatively fusion with healthy mitochondria, in or near the soma (<xref ref-type="bibr" rid="bib30">Hollenbeck, 1993</xref>; <xref ref-type="bibr" rid="bib55">Miller and Sheetz, 2004</xref>; <xref ref-type="bibr" rid="bib51">Maday et al., 2012</xref>; <xref ref-type="bibr" rid="bib52">Maday and Holzbaur, 2014</xref>; <xref ref-type="bibr" rid="bib12">Cheng et al., 2015</xref>; <xref ref-type="bibr" rid="bib107">Zheng et al., 2019</xref>; <xref ref-type="bibr" rid="bib21">Evans and Holzbaur, 2020</xref>). Consistent with these studies, there is evidence that axonal autophagy initiates preferentially at the distal tips or presynaptic sites of axons and terminates the clearance process at the soma (<xref ref-type="bibr" rid="bib105">Yue, 2007</xref>; <xref ref-type="bibr" rid="bib94">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="bib85">Soukup et al., 2016</xref>; <xref ref-type="bibr" rid="bib86">Stavoe et al., 2016</xref>). Indeed, <italic>Pink1</italic> mRNA can be transported to distal regions of neurons and translated locally, providing a constant supply of fresh PINK1 protein for axonal mitochondria, and that this mechanism might enable mitochondria to be at least tagged for degradation in the distal regions of axons (<xref ref-type="bibr" rid="bib27">Harbauer et al., 2022</xref>). However, other studies have demonstrated that axonal mitochondria in mid- or distal-axons tend to be older and more susceptible to damage when compared to those residing in the proximal axons or cell body (<xref ref-type="bibr" rid="bib43">Lehmann et al., 2011</xref>; <xref ref-type="bibr" rid="bib24">Ferree et al., 2013</xref>), and that the vulnerable or stressed axonal mitochondria have diminished mitochondrial motility compromising their ability to return to the soma for degradation (<xref ref-type="bibr" rid="bib93">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Lovas and Wang, 2013</xref>; <xref ref-type="bibr" rid="bib3">Ashrafi et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Hsieh et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Cheng and Sheng, 2021</xref>), implying that not only initiating but also completing mitophagy locally in the axon may be needed to effectively remove arrested old or damaged mitochondria in long axons.</p><p>We previously reported that in the optic nerve head of mice, an alternative mechanism exists to degrade axonal mitochondria, whereby outpocketings of axons containing mitochondria are pinched off from the axons and are degraded by the local astrocytes (<xref ref-type="bibr" rid="bib16">Davis et al., 2014</xref>). Although they occurred elsewhere in the central nervous system, including in the cerebral cortex, these sheddings were most numerous in the optic nerve head, which is both a highly specialized anatomical structure where axons are constantly subjected to biomechanical stress and is also the site of axon damage in glaucoma (<xref ref-type="bibr" rid="bib7">Burgoyne et al., 2005</xref>; <xref ref-type="bibr" rid="bib82">Sigal et al., 2005</xref>). More recently, similar sheddings of mitochondria have been observed in both Parkinson’s and Alzheimer’s disease rodent animal and cell models (<xref ref-type="bibr" rid="bib62">Morales et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Lampinen et al., 2022</xref>) as well as in cone photoreceptors (<xref ref-type="bibr" rid="bib33">Hutto et al., 2023</xref>).</p><p>OPTN is one of the very few genes that have a large effect on glaucoma (<xref ref-type="bibr" rid="bib75">Rezaie et al., 2002</xref>; <xref ref-type="bibr" rid="bib54">Meng et al., 2012</xref>), and the mutations in OPTN that promote glaucoma but not those that promote Amyotrophic Lateral Sclerosis (ALS) act in a gain-of-function manner to promote more or dysregulated mitophagy (<xref ref-type="bibr" rid="bib100">Wong and Holzbaur, 2014a</xref>; <xref ref-type="bibr" rid="bib83">Sirohi et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Shim et al., 2016</xref>). Since mutations in mitophagy machinery result in damage to axons in the optic nerve head (<xref ref-type="bibr" rid="bib57">Minegishi et al., 2016</xref>), and this is the location with the highest amounts of transcellular mitochondrial degradation (<xref ref-type="bibr" rid="bib16">Davis et al., 2014</xref>), the current study sought to determine whether mutations in OPTN associated with glaucoma might lead to alterations in the non-cell-autonomous degradation of mitochondria. Since much of what has been learned about OPTN in mitophagy derives from live-imaging studies of mitochondria and mitophagic machinery in cultured cells (<xref ref-type="bibr" rid="bib42">Lazarou et al., 2015</xref>; <xref ref-type="bibr" rid="bib61">Moore and Holzbaur, 2016</xref>; <xref ref-type="bibr" rid="bib81">Shim et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Evans and Holzbaur, 2020</xref>), we took a live-imaging approach where the anatomical relationship between axons and their cellular neighbors is maintained, as these cell–cell interactions are likely necessary to reproduce the relevant cell biology. These studies were carried out in young <italic>Xenopus laevis</italic> tadpoles, as this vertebrate model system has two properties optimal for the proposed studies: an optic nerve that can be readily live-imaged and a highly efficient transgenesis suitable for the interrogation of gene variants.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Live imaging of mitochondria in RGC axons shows that under basal conditions approximately half of axonal mitochondria are stopped</title><p>To live-image RGC mitochondria within axons, we first intravitreally injected Mitotracker Deep Red into <xref ref-type="bibr" rid="bib70">Nieuwkoop and Faber, 1994</xref> stage 48 (10 days post-fertilization) <italic>X. laevis</italic> tadpoles, animals whose RGC axons were readily visible due to expression of an RGC-specific <italic>Tg(Isl2b:GFP)</italic> transgene (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). After allowing the dye to spread down the axons, the optic nerves of anesthetized and immobilized animals were imaged using a spinning disc confocal microscope (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, and <xref ref-type="video" rid="fig1video1">Figure 1—video 1</xref>, top) at 1 Hz for 1 min, to measure axonal mitochondria movement through kymographs (<xref ref-type="fig" rid="fig1">Figure 1C, D</xref>). Since the morphology and movement of mitochondria labeled by Mitotracker were similar to those labeled by an RGC-specific <italic>Tg(Tom20-mCherry)</italic> transgene (<xref ref-type="video" rid="fig1video1">Figure 1—video 1</xref>, bottom), intravitreal Mitotracker injection was deemed suitable for labeling RGC mitochondria in the optic nerve. To determine the stability of Mitotracker labeling over time, optic nerves were imaged 3.5 or 18 hr after intravitreal Mitotracker injection. Since the distribution (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) and velocity (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) of stationary, anterogradely moving, and retrogradely moving mitochondria were similar at both time points, all subsequent imaging experiments were carried out 15–18 hr after Mitotracker intravitreal injection. The kymographs of axonal RGC mitochondria were used to determine the fraction of mitochondria that were stationary, defined here as moving less than 0.1 μm/s, as opposed to moving anterogradely and retrogradely (<xref ref-type="fig" rid="fig1">Figure 1C, D</xref>). In an analysis of over 500 axonal mitochondria derived from 6 animals, we found that stationary mitochondria account for nearly half of the total axonal mitochondria, whereas both anterogradely and retrogradely transported mitochondria each contribute a quarter of the total (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), consistent with other studies of axonal mitochondria (<xref ref-type="bibr" rid="bib107">Zheng et al., 2019</xref>; <xref ref-type="bibr" rid="bib23">Fellows et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Suh et al., 2021</xref>). Among the motile mitochondria, the average speed was 0.63 and 0.78 μm/s for anterogradely and retrogradely moving mitochondria, respectively (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), which is within the range of the values previously measured by others (<xref ref-type="bibr" rid="bib63">Morris and Hollenbeck, 1993</xref>; <xref ref-type="bibr" rid="bib45">Ligon and Steward, 2000</xref>; <xref ref-type="bibr" rid="bib17">De Vos et al., 2003</xref>; <xref ref-type="bibr" rid="bib55">Miller and Sheetz, 2004</xref>; <xref ref-type="bibr" rid="bib34">Jiménez-Mateos et al., 2006</xref>; <xref ref-type="bibr" rid="bib73">Pilling et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Mironov, 2007</xref>; <xref ref-type="bibr" rid="bib59">Misgeld et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Kang et al., 2008</xref>; <xref ref-type="bibr" rid="bib92">Wang and Schwarz, 2009</xref>; <xref ref-type="bibr" rid="bib50">MacAskill and Kittler, 2010</xref>; <xref ref-type="bibr" rid="bib9">Chang et al., 2011</xref>; <xref ref-type="bibr" rid="bib11">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib69">Niescier et al., 2016</xref>). Thus, the <italic>X. laevis</italic> tadpole optic nerve was deemed a suitable model to study RGC axonal mitochondria.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Live-imaging mitochondria movement within <italic>X</italic>. <italic>laevis</italic> tadpole optic nerve shows that in retinal ganglion cell (RGC) axons approximately half of mitochondria are stopped and there is balanced anterograde and retrograde movement.</title><p>(<bold>A</bold>) Intravitreal injection of Mitotracker Deep Red can be used to label RGC mitochondria within axons; here in <italic>Tg(Isl2b:GFP)</italic> transgenic tadpoles where the RGC axons are also labeled by a cytoplasmic GFP expressed by the <italic>Isl2b</italic> RGC-specific promoter. The white dotted box illustrates the approximate location of spinning-disc confocal live imaging (1 min, 1 Hz). Representative single frame of a Mitotracker Deep Red labeled optic nerve full region imaged in (<bold>B</bold>); boxed area rotated and enlarged in (<bold>C</bold>). (<bold>D</bold>) Representative kymograph displaying the position (<italic>x</italic>-axis) of mitochondria over time (<italic>y</italic>-axis, 60 s); derived from the region between the dotted lines in C for all 60 frames. The yellow star indicates the position of the same mitochondrion in both kymograph (<bold>D</bold>) and representative image (<bold>C</bold>). Scale bar, 10 µm. Quantification of mitochondrial movements, showing that (<bold>E</bold>) about half of RGC axonal mitochondria are stationary and there are comparable numbers of mitochondria moving anterogradely and retrogradely, and (<bold>F</bold>) the average speed of anterograde and retrograde mitochondria movement is similar. Mean ± SEM; <italic>n</italic> = 514 mitochondria from 6 animals. Statistical analysis in (<bold>F</bold>) was performed by unpaired, two-tailed Student’s <italic>t</italic>-test. Not significant (ns).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Intravitreal Mitotracker injection results in optic nerve mitochondria labeling that is stable within 1 day of injection, labels transgenically labeled retinal ganglion cell (RGC) axonal mitochondria, and has a small but significant effect on the movement behavior of axonal mitochondria.</title><p>(<bold>A</bold>, <bold>B</bold>) RGC axonal mitochondrial movement metrics are stable within the optic nerve between 3.5 and 18 hr after intravitreal Mitotracker injection. (<bold>A</bold>) Percentage of stationary, and anterogradely and retrogradely moving mitochondria and (<bold>B</bold>) axonal mitochondrial average speed in each direction (anterograde and retrograde). Mean ± SEM; <italic>n</italic> = 237–277 mitochondria from 3 animals. A Tom20-mCherry transgene expressed by the RGC-specific <italic>Isl2b</italic> promoter and intravitreal Mitotracker injection both label largely the same mitochondria in the optic nerve; representative images (<bold>C</bold>) and corresponding kymographs (<bold>D</bold>). (<bold>E</bold>, <bold>F</bold>) Quantification of mitochondrial movements in RGC axons based on either Mitotracker or a Tom20-mCherry transgene. From left to right, the measurement based on Mitotracker-labeled objects in Mitotracker-injected <italic>Tg(Isl2b:GFP)</italic> animals, Mitotracker-labeled objects in Mitotracker-injected <italic>Tg(Isl2b:GFP x Isl2b:Tom20-mCherry)</italic> animals, Tom20-labeled objects in <italic>Tg(Isl2b:GFP x Isl2b:Tom20-mCherry)</italic> animals, Tom20-labeled objects in Mitotracker-injected <italic>Tg(Isl2b:GFP x Isl2b:Tom20-mCherry)</italic> animals. Mean ± SEM; <italic>n</italic> = 1187–1610 mitochondria from 4 animals. Statistical analysis in (<bold>A</bold>), (<bold>B</bold>), (<bold>E</bold>), and (<bold>F</bold>) was performed by two-way ANOVA following Tukey’s post hoc test for multiple comparisons. Not significant (ns), ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig1-figsupp1-v2.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-103844-fig1-video1.mp4" id="fig1video1"><label>Figure 1—video 1.</label><caption><title>Intravitreal injection of Mitotracker and retinal ganglion cell (RGC)-expressed Tom20-mCherry transgene similarly labels axonal mitochondria.</title><p>Time-lapse (1  Hz, 1  min) showing comparable mitochondrial morphology and motility in RGC axons labeled with Mitotracker Deep Red (top) and Tom20mCherry (bottom). Scale bar, 10 µm.</p></caption></media></fig-group><p>Next, to test whether the Mitotracker intravitreal injection itself might affect mitochondria movement within the optic nerve, we crossed <italic>Tg(Isl2b:GFP)</italic> and <italic>Tg(Isl2b:Tom20-mCherry)</italic> animals and obtained doubly transgenic animals which express both a mitochondria-targeted mCherry fluorescent reporter as well as a cytoplasmic GFP transgene, both specifically in RGCs. Mitotracker Deep Red was injected into <italic>Tg(Isl2b:GFP)</italic> expressing tadpoles at NF stage 48, into both animals with or without expression of the Isl2b:Tom20-mCherry transgene, and then the optic nerves were live-imaged as described above within 1 day of the intravitreal Mitotracker injection. The Mitotracker-based quantifications showed no significant difference in mitochondria movement between the two different Mitotracker-injected groups (with and without presence of the mitochondria-targeted transgene), whereas the Tom20-based quantifications showed that the Mitotracker intravitreal injection does have a small but significant effect on slowing retrograde transport and increasing the fraction of stopped mitochondria at the expense of anterograde moving mitochondria (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F, E</xref>, respectively). Because of this effect, in all subsequent experiments, animals with or without intravitreal injection were compared only to other animals similarly treated.</p></sec><sec id="s2-2"><title>Doxycycline-induced expression in RGCs of disease-associated OPTN mutants leads to changes in the movement of OPTN and LC3b and, in the case of OPTN E50K, also the movement of mitochondria as well as the co-localization of OPTN and mitochondria</title><p>Mutations in OPTN can lead to impaired or aberrant mitophagy and the accumulation of defective mitochondria (<xref ref-type="bibr" rid="bib100">Wong and Holzbaur, 2014a</xref>; <xref ref-type="bibr" rid="bib42">Lazarou et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Shim et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Evans and Holzbaur, 2020</xref>). To test whether OPTN mutations might affect the behavior of RGC mitochondria and components of the mitophagic machinery, OPTN and LC3b, specifically within axons, we generated transgenic <italic>X. laevis</italic> in which fluorescently tagged LC3b and variants of OPTN could be expressed selectively in RGCs by induction with doxycycline (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref>). In these large transgene constructs, regulatory regions from the zebrafish Isl2b gene (<xref ref-type="bibr" rid="bib74">Pittman et al., 2008</xref>) which drive RGC-specific expression in the <italic>X. laevis</italic> retina (<xref ref-type="bibr" rid="bib97">Watson et al., 2012</xref>), were here used to drive a version of the reverse tetracycline trans-activator, rtTA2, that is highly efficient in <italic>X. laevis</italic> (<xref ref-type="bibr" rid="bib15">Das and Brown, 2004</xref>; <xref ref-type="bibr" rid="bib56">Mills et al., 2015</xref>) in plasmids that also contain a bidirectional tetracycline operator that expresses EGFP-LC3b in one direction and in the other mCherry-tagged versions of the following human OPTN variants: Wt, glaucoma-associated mutations E50K, M98K, and H486R, ALS-associated mutation E478G, and two synthetic mutations, F178A and D474N, previously shown to be defective in the OPTN interaction with LC3b and ubiquitinated mitochondria, respectively (<xref ref-type="bibr" rid="bib99">Wild et al., 2011</xref>; <xref ref-type="bibr" rid="bib38">Korac et al., 2013</xref>; <xref ref-type="bibr" rid="bib100">Wong and Holzbaur, 2014a</xref>; <xref ref-type="bibr" rid="bib83">Sirohi et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Shim et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="bib14">Chernyshova et al., 2019</xref>; <xref ref-type="bibr" rid="bib72">Padman et al., 2019</xref>). The optic nerves of 4–6 transgenic tadpoles per transgene were imaged using the spinning-disc confocal first as a 1-min single plane t-series acquired at 1 Hz, and then as a z-scan imaging the full thickness of the optic nerve at 1 µm steps. In the case of animals expressing E50K and Wt OPTNs, analyses were done with and without previous labeling of RGC mitochondria through intravitreal injection of Mitotracker (<xref ref-type="fig" rid="fig2">Figure 2C, D</xref>); in the case of all other OPTN variants, analyses of OPTN and LC3b were carried only without Mitotracker labeling. Kymograph analyses of the t-series were used to quantify the percentage of each movement class (stationary, anterograde, and retrograde) and determine the average speed of anterograde and retrograde movement. For the live-imaging and kymograph analyses of OPTN and LC3b, in the absence of Mitotracker intravitreal injection, analyses were carried out in both primary transgenic F0 animals (<xref ref-type="fig" rid="fig2">Figure 2E, E’</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C, D</xref>) as well as in their F1 progeny (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A, B, E, F</xref>), to minimize the possibilities of transgene copy number or integration position effects confounding the interpretation. Such analyses in F0s are possible in <italic>X. laevis</italic> because the restriction enzyme-mediated integration transgenesis method used to generate the animals (<xref ref-type="bibr" rid="bib39">Kroll and Amaya, 1996</xref>) involves transgene integration prior to the first cell division, and thus provides fully transgenic rather than mosaic animals. The results from F0 transgenic founders and F1 progeny were similar and showed that relative to Wt OPTN, all OPTN mutants with the exception of the LC3b-binding-defective F178A increased the fraction of stopped OPTN or LC3b in either F0 or F1 experiments. However, it was only the glaucoma-associated E50K and M98K mutations that increased stopped OPTN in both F0 and F1 analyses, and only the E50K mutation that increased both OPTN and LC3b in both F0 and F1 analyses. Analyses of anterograde and retrograde velocity for OPTN and LC3b in both F0s (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C, D</xref>) and F1 animals (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E, F</xref>) were generally consistent with one another. Overall, there were no consistent significant changes in velocity in both F0 and F1 analyses, suggesting the increases in stopped OPTN and LC3b were specific effects and not secondary to making the RGCs or their axons unhealthy. To determine whether the observed increases in stopped OPTN and LC3b might represent an increase in axonal mitophagy, the studies of OPTN and LC3b movement were repeated, but now 15–18 hr after intravitreal injection of Mitotracker (<xref ref-type="fig" rid="fig2">Figure 2F</xref>); these studies were carried just in F1 animals expressing Wt or E50K OPTN, as well as in animals carrying no transgenes at all. Compared to the non-transgenic control animals (only Mitotracker-injected), those with expression of Wt OPTN had no alteration in the fraction of stopped mitochondria, similar to what had been previously observed after expression of the Tom20-mCherry transgene (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>), though they did have a small effect on the velocity of retrogradely transported mitochondria (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>); this effect on retrograde velocity was similar after both Wt and E50K OPTN expression. In contrast, expression of E50K OPTN uniquely resulted in a significant increase in the fraction of stopped mitochondria, above the already high baseline amount (<xref ref-type="fig" rid="fig2">Figure 2F</xref>), without affecting retrograde transport any further (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>). Of note, as was the case for OPTN and LC3b in the absence of intravitreal Mitotracker injection, expression of neither Wt nor E50K OPTN affected the relative balance of retrograde versus anterograde movement of mitochondria, OPTN, or LC3b but rather only affected the fraction of the stopped populations. Consistent with the previous results showing that intravitreal injection of Mitotracker had a small but significant effect on mitochondria movement (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E, F</xref>), here too we found that the intravitreal injection of Mitotracker affected the behavior of axonal OPTN, including an increase in the fraction of stopped OPTN; however, so did animals receiving an injection of just the biological salts solvent, showing that it is the eye injection procedure rather than the Mitotracker itself that modestly perturbs the system (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>OPTN mutants conditionally expressed in retinal ganglion cells (RGCs) increase the fraction of stopped axonal mitochondria, OPTN and LC3b, and the fraction of mitochondria co-localizing with OPTN.</title><p>(<bold>A</bold>) Illustration of the transgenic construct: Isl2b promoter driving rtTA2 linked to EGFP-LC3b and mCherry-OPTN driven in opposite strands by a bidirectional tetracycline operator, TetBI. The fusion constructs are thus expressed only in RGCs and only after doxycycline induction. (<bold>B</bold>) Schematic of OPTN functional domains showing the position of the point mutations examined. Three glaucoma-associated mutations, E50K, M98K, and H486R; an ALS-associated mutation, E478G; two synthetic OPTN mutations, F178A and D474N, disrupting LC3b and ubiquitin binding, respectively. CC: coiled coil domain, LIR: LC3 interacting region, UBD: ubiquitin-binding domain, ZF: zinc finger. Numbers indicate the amino acid position. Representative confocal images (<bold>C</bold>) and corresponding kymographs (<bold>D</bold>) of axonal mitochondria, OPTN, and LC3b in Mitotracker-injected <italic>Tg(Isl2b:mCherry-OPTN(Wt or E50K)_ EGFP-LC3b</italic>) animals 3 days after induction of transgene expression. Scale bar, 10 µm. Quantification of OPTN (<bold>E</bold>) and LC3b (<bold>E’</bold>) movements in Wt OPTN and various OPTN mutants (all independent F0 animals). Bar graphs show the percentage of each movement (stationary, anterograde, and retrograde) of OPTN and LC3b in Wt OPTN and OPTN mutants. Mean ± SEM; <italic>n</italic> = 63–652 OPTN and <italic>n</italic> = 156–259 LC3b objects measured in 4–8 animals. (<bold>F</bold>) Quantification of mitochondrial movements after Mitotracker injection in control (non-transgenic), and transgenic animals expressing in RGCs either Wt or E50K OPTN (analyzed in F1 animals). Expression of E50K OPTN but not Wt OPTN results in a significant increase in stalled mitochondria compared to the control. Mean ± SEM; <italic>n</italic> = 237–2448 mitochondria from 3 to 6 animals. Quantification of mito-OPTN co-localization in Mitotracker-injected Wt OPTN (<bold>G</bold>, <bold>H</bold>) and E50K OPTN (<bold>H</bold>) animals. (<bold>G</bold>) Percentage of each movement (stationary, anterograde, and retrograde) of mitochondria co-localizing (mito-OPTN) or not co-localizing (mito-ONLY) with OPTN in the animals expressing Wt OPTN. Mean ± SEM; <italic>n</italic> = 1550 mito-ONLY, <italic>n</italic> = 537 mito-OPTN co-localizations from 4 Wt OPTN animals. (<bold>H</bold>) Expression of E50K OPTN results in increased fraction of mito-OPTN (mitochondria-OPTN co-localization) relative to Wt OPTN, both in the moving and stationary pools. Mean ± SEM; <italic>n</italic> = 658–930 total anterograde mitochondria, <italic>n</italic> = 632–938 total retrograde mitochondria, <italic>n</italic> = 1017–3246 total stationary mitochondria from 4 to 6 animals. Statistical analysis in (<bold>E</bold>–<bold>H</bold>) was performed by two-way ANOVA following Tukey’s post hoc test for multiple comparisons. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Movement of OPTN and LC3b in F1 animals (not injected intravitreally with Mitotracker) matches those observed in F0 animals, including showing no large velocity changes in either anterograde or retrograde movement.</title><p>Percentage of each movement (stationary, anterograde, and retrograde) of OPTN (<bold>A</bold>) and LC3b (<bold>B</bold>) in F1 transgenic animals and (<bold>C</bold>–<bold>F</bold>) average speed of axonal OPTN and LC3b in each direction (anterograde and retrograde) in F0 (<bold>C</bold>, <bold>D</bold>) and F1 (<bold>E</bold>, <bold>F</bold>) transgenic animals. Mean ± SEM; <italic>n</italic> = 155–912 OPTN from 4 to 6 animals. <italic>n</italic> = 67–474 LC3b from 4 to 6 animals. (<bold>G</bold>) Average anterograde and retrograde speed in control (non-transgenic, only Mitotracker-injected animals), and Wt OPTN and E50K OPTN expressing retinal ganglion cell (RGC) axons. Mean ± SEM; <italic>n</italic> = 237–2448 mitochondria from 3 to 6 animals. (<bold>H</bold>) Fraction of stopped and moving OPTN in animals expressing Wt OPTN in the presence and absence of intravitreal injections (0.5X MMR solvent or Mitotracker injections). Mean ± SEM; <italic>n</italic> = 819–1242 OPTN objects measured in 11–12 animals. (<bold>I</bold>) Quantification of mito-OPTN co-localizations in Mitotracker-injected E50K OPTN animals. Percentage of each movement (stationary, anterograde, and retrograde) of mitochondria co-localizing with (mito-OPTN) or not co-localizing with (mito-ONLY) OPTN in E50K OPTN expressing animals. Mean ± SEM; <italic>n</italic> = 2305 mito-ONLY, <italic>n</italic> = 2676 mito-OPTN co-localizations from 6 E50K OPTN animals. Statistical analysis in (<bold>A</bold>–<bold>I</bold>) was performed by two-way ANOVA following Tukey’s post hoc test for multiple comparisons. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001 after 24 hr treatment with chloroquine. Mean ± SD; <italic>n</italic> = 11–12 animals.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Next, to determine whether the increases in stopped mitochondria and stopped OPTN might be linked, the degree of mitochondria and OPTN co-localization was examined. In the nerves labeled by Mitotracker, visual inspection of the raw images (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) and the derived kymographs (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) was suggestive that OPTN and the Mitotracker-labeled mitochondria might co-localize, particularly in the stopped populations, and more so in the animals expressing E50K OPTN. To examine the degree of mitochondria and OPTN co-localization quantitatively, we re-analyzed the previous kymographs of mitochondria and OPTN and separately quantified mitochondria that co-localized, with OPTN (mito-OPTN) versus mitochondria not associated with OPTN (mito-ONLY) (<xref ref-type="fig" rid="fig2">Figure 2G</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1I</xref>). Strikingly, while mitochondria not co-localizing with OPTN had relatively balanced populations of stopped, and anterogradely and retrogradely moving, the majority of mitochondria co-localizing with OPTN were stopped, with the remainder being largely engaged in retrograde transport; the same was true in animals expressing Wt OPTN (<xref ref-type="fig" rid="fig2">Figure 2G</xref>) and E50K OPTN (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1I</xref>). The glaucoma-associated E50K OPTN also significantly increased the fraction of mitochondria co-localizing with OPTN, and this increased co-localization was observed not only in the stationary but also the two moving populations (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). In summary, expression of OPTN versions carrying glaucoma and ALS-associated mutations, as well as a synthetic mutation in OPTN that perturbs the recognition of ubiquitinated mitochondria, but not a synthetic mutation that perturbs the association of OPTN with LC3b, all had or trended to increases in stopped axonal OPTN and LC3b in RGCs, and the two that had the largest and most consistent effects were two glaucoma-associated mutations, E50K and M98K, with E50K having an increased co-localization with mitochondria and leading to a greater fraction of stopped mitochondria within the optic nerve.</p><p>Since OPTN associates with damaged mitochondria when mediating mitophagy, we asked whether some of the stopped mitochondria co-localizing with OPTN measured in our kymographs might be mitochondria undergoing mitophagy. If so, inhibiting autophagosome-lysosome fusion with chloroquine would be expected to affect the number of these stopped mitochondria. Surprisingly, as measured by the Tom20-mCherry mitochondria reporter, neither the total number (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>) nor the proportions of mitochondria stopped or moving in either direction (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>) were affected by 24 hr of chloroquine treatment. These negative results lead us to confirm the efficacy of chloroquine in our system by using transgenic animals expressing the autophagosome/autophagolysosome reporter LC3b-EGFP-mCherry, expressed in astrocytes through a promoter from the fatty acid binding protein 7 gene (<italic>fabp7</italic>, also known as basic lipid binding protein or <italic>blbp</italic>) (<xref ref-type="bibr" rid="bib71">Owada et al., 1996</xref>; <xref ref-type="bibr" rid="bib80">Sharifi et al., 2011</xref>), which drives expression in frog optic nerve astrocytes (<xref ref-type="bibr" rid="bib56">Mills et al., 2015</xref>). While discrete green or red puncta were rare, chloroquine did result in the expected increase in green puncta that report autophagosomes that have not yet fused with lysosomes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Within some of those autophagosomes, there was Mitotracker signal (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>), suggesting that at least some axonal mitochondria might be degraded by astrocyte autophagolysosomes. To quantify the extent of RGC axonal mitochondria found in the optic nerve outside of the axons, the same chloroquine treated animals were analyzed as z-scans of the full thickness of optic nerves acquired at 1 µm steps, followed by measurements using 3D imaging software Imaris of the Tom20-mCherry signal inside or out of a mask based on a membrane GFP transgene expressed by the same axons (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E, F</xref>). Such analyses showed that 21.4% of the Tom20-mCherry signal is outside of the axons, much of it near the surface of the optic nerve, but that amount is not significantly altered by 24 hr of chloroquine treatment (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G</xref>). Note that this measure of axonal mitochondria outside axons likely relates to only the stopped mitochondria, as the z-scan imaging used frame-averaging and thus moving objects were blurred and likely underrepresented. Thus, in our system, the stopped mitochondria co-localizing with OPTN appear not to be degraded by conventional mitophagy.</p><p>Since in many of the animals some OPTN signal appeared not to be co-localized with the LC3b signal but rather to also be on the surface of the optic nerve (e.g., middle top of the OPTN E50K nerve shown in <xref ref-type="fig" rid="fig2">Figure 2C</xref>), similar to what was observed with the axon expressed Tom20-mCherry transgene, we then asked whether significant amounts of OPTN might also be found outside of axons, and if so, whether the OPTN mutations affected how much. Because LC3b localizes not only to autophagosomal membranes, but also is in the cytoplasm/axoplasm (<xref ref-type="bibr" rid="bib102">Xie and Klionsky, 2007</xref>; <xref ref-type="bibr" rid="bib60">Mizushima and Komatsu, 2011</xref>; <xref ref-type="bibr" rid="bib25">Fu et al., 2014</xref>; <xref ref-type="bibr" rid="bib101">Wong and Holzbaur, 2014b</xref>; <xref ref-type="bibr" rid="bib91">Tammineni et al., 2017</xref>; <xref ref-type="bibr" rid="bib87">Stavoe et al., 2019</xref>; <xref ref-type="bibr" rid="bib21">Evans and Holzbaur, 2020</xref>; <xref ref-type="bibr" rid="bib6">Boecker et al., 2021</xref>; <xref ref-type="bibr" rid="bib40">Kuijpers et al., 2021</xref>), we used the EGFP-LC3b signal to create a mask to demark the RGC axons, so as to then be able to separately measure the OPTN (mCherry) or mitochondria (far-red) signals that co-localized or not with the axons. First, such analyses of OPTN outside axons were carried out for the same animals above analyzed for OPTN and LC3b movement metrics, but that had not been subjected to the intravitreal injections of Mitotracker, animals in which the expression of mCherry-hOPTNs (Wt, E50K, M98K, F178A, D474N, E478G, and H486R) and EGFP-LC3b was induced in RGCs through bath application of doxycycline. Measurements carried out in the 3D reconstructions showed significant increases in the fraction of OPTN outside of the RGC axons in the optic nerves of glaucoma-associated mutations, especially E50K (12.6%), when compared to Wt OPTN (0.5%), ALS-associated mutation E478G (0.2%), and the synthetic mutations F178A (3.3%) and D474N (0.1%) (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>). Then, to determine whether such extra-axonal OPTN might be associated with mitochondria, the same procedure was applied to the z-scan images of animals where Wt OPTN and E50K OPTN were similarly induced by doxycycline, but that also a day prior had received an intravitreal injection of Mitotracker (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Imaris-based 3D reconstruction and volume quantification revealed that expression of OPTN carrying the glaucoma-associated E50K mutation results in a significant increase in both the fraction of RGC axonal mitochondria outside of the LC3b-labeled RGC axons (13.4%) but also the fraction of all stopped RGC axonal mitochondria co-localizing with OPTN also outside of the LC3b-labeled RGC axons (17.9%), as compared to the much lower amounts found after expression of Wt OPTN (2.7% for mitochondria and 0.5% for mito-OPTN) (<xref ref-type="fig" rid="fig3">Figure 3D, E</xref>). Note that the amount of mitochondrial signal measured outside of axons based on Mitotracker labeling is less than that estimated to be outside based on the Tom20mCherry transgene. In summary, expression of E50K OPTN, but not OPTN that lacks the glaucoma-associated mutation, not only increases the amount of stopped mitochondria, OPTN and LC3b, and the degree of co-localization between mitochondria and OPTN within axons but also increases the amounts of mitochondria and the mitophagy receptor OPTN being found outside of the axons, much of which also co-localize outside of the axons.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>3D reconstruction of axonal mitochondria, OPTN and LC3b in optic nerves shows that glaucoma-associated OPTN mutations increase the amounts of mitochondria, OPTN, and mito-OPTN outside of the LC3b-labeled axons.</title><p>(<bold>A</bold>) Reconstruction of optic nerves displaying OPTN, LC3b, and OPTN outside LC3b-labeled retinal ganglion cell (RGC) axons (merged images on the right) in the optic nerves of animals expressing Wt and E50K OPTN. D: dorsal, V: ventral, C: caudal, R: rostral. Scale bar, 10 µm. (<bold>B</bold>) Percentage of OPTN outside LC3b-labeled RGC axons is significantly higher or trends so in the glaucoma-associated OPTN mutations. Mean ± SEM; <italic>n</italic> = 5–6 animals. (<bold>C</bold>–<bold>E</bold>) 3D reconstruction of axonal mitochondria, OPTN, and LC3b within the segments of intraocular optic nerves in Mitotracker-injected <italic>Tg(Isl2b:mCherry-OPTN(Wt or E50K)_ EGFP-LC3b) X. laevis</italic>. (<bold>C</bold>) Reconstruction displaying mitochondria, OPTN, LC3b, mito-OPTN co-localization, and mito-OPTN outside LC3b-labeled RGC axons (merged images on the bottom) in the optic nerves of animals expressing Wt and E50K OPTN. D: dorsal, V: ventral, C: caudal, R: rostral. Scale bar, 10 µm. Percentage of mitochondria (<bold>D</bold>) and mito-OPTN (<bold>E</bold>) outside of LC3b-labeled RGC axons after expression of Wt and E50K OPTN. Expression of E50K OPTN results in a significant increase in mitochondria and mito-OPTN co-localizations outside of LC3b-labeled RGC axons. Mean ± SEM; <italic>n</italic> = 3–5 animals. Statistical analysis in (<bold>B</bold>) was performed by one-way ANOVA following Tukey’s post hoc test for multiple comparisons, and (<bold>D</bold>, <bold>E</bold>) was performed by unpaired, two-tailed Student’s <italic>t</italic>-test. *p &lt; 0.05, ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Inhibiting autophagolysosome formation through chloroquine minimally affects retinal ganglion cell (RGC) axonal mitochondria degradation.</title><p>(<bold>A</bold>) Quantification of Tom20-mCherry puncta number per axon segment imaged in the presence or absence of chloroquine for 24 hr. Mean ± SD. (<bold>B</bold>) Quantification of Tom20-mCherry movements showing the percentage of each movement (stationary, anterograde, and retrograde; black, light gray, and dark gray, respectively) in the presence or absence of chloroquine for 24 hr. <italic>N</italic> and <italic>n</italic> represent the number of animals and mitochondria analyzed. (<bold>C</bold>) EGFP+ autophagosome puncta increase in astrocytes expressing EGFP-mCherry-LC3b reporter in response to 10 hr of chloroquine treatment. (<bold>D</bold>) In the presence of chloroquine, some EGFP+ autophagosome puncta contain RGC mitochondria. (<bold>E</bold>) 3D reconstructions of raw fluorescence and Imaris-generated masks used for quantifications for RGC expressed membrane-GFP (mGFP) and mitochondria (Tom20-mCherry) transgenes. D: dorsal, V: ventral, C: caudal, R: rostral. Scale bar, 10 µm. (<bold>F</bold>) Percentage of RGC Tom20-mCherry signal outside of lynkGFP-labeled RGC axons is not significantly affected by chloroquine treatment.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig3-figsupp1-v2.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-103844-fig3-video1.mp4" id="fig3video1"><label>Figure 3—video 1.</label><caption><title>E50K OPTN expression increases the amount of MitoOPTN outside of axons.</title><p>3D z-stack reconstructions: E50K OPTN increases co-localization of Mitotracker-labeled mitochondria and mCherry-OPTN outside EGFPLC3b-marked axons. Scale bar, 10 µm.</p></caption></media></fig-group></sec><sec id="s2-3"><title>Sparse labeling of axons shows even larger amounts of axonal mitochondria and OPTN are outside of axons and that only in the most extreme cases are they observed on the ON surface</title><p>In the experiments just described, much LC3b-negative-OPTN-positive mitochondria signal was found on what appears to be the surface of the optic nerve, which was most obvious after expression of E50K OPTN (see <xref ref-type="fig" rid="fig3">Figure 3A, C</xref>, and <xref ref-type="video" rid="fig3video1">Figure 3—video 1</xref>). To determine whether additional extra-axonal OPTN and mitochondria might be found within the optic nerve parenchyma but obscured by the EGFP-LC3b mask due to the high axon density and low imaging resolution, we turned to a sparse labeling approach. Small groups of retinal cells, estimated to be 10–50 in number, were surgically transplanted from E50K OPTN transgenic progeny into progeny of a line expressing <italic>Tg(Fabp7:mTagBFP2-Ras)</italic>, in which astrocyte membranes are labeled by a membrane-targeted BFP reporter. Transplants were done around NF stage 24–32, when all cells in the retina are progenitors and thus prior to RGC differentiation. A week later in such animals and 3 days after doxycycline induction, small groups of axons were readily visible in these optic nerves based on the EGFP-LC3b signal. 3D reconstruction and volume measurements of the astrocyte membrane signal derived from the host and the OPTN and LC3b signals derived from E50K OPTN expressing donor cells (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>, and <xref ref-type="video" rid="fig4video1">Figure 4—video 1</xref>) showed that the fraction of OPTN signal on the surface of the optic nerve was 17.1% of the total signal, in relatively good agreement with the data previously obtained in the whole nerves (see <xref ref-type="fig" rid="fig3">Figure 3B</xref>). However, this represented only 23.9% of the total OPTN outside of the LC3b-labeled axons, the rest being within the optic nerve parenchyma. Furthermore, the nerves with the largest amounts of OPTN on the surface of the optic nerve were those with the greatest amount of extra-axonal OPTN (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). These sparse labeling data thus suggested that our previous measures of OPTN and mitochondria outside of axons quantified in <xref ref-type="fig" rid="fig4">Figure 4</xref> based on the whole-nerve imaging after expression of all OPTN variants likely grossly underreported the actual amounts of OPTN and mitochondria outside of the axons. Thus, for animals expressing either Wt or E50K OPTN, we repeated the same t-series and z-scan imaging and following kymograph analyses and Imaris 3D reconstructions in the context of the sparse labeled axons, but also after dye-labeling the mitochondria prior to transplantation. That is, 1 hr after injection of Mitotracker into the eye anlage, retina progenitor cells from Wt or E50K OPTN transgenic progeny were transplanted into the eyes of non-transgenic hosts (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, B</xref>). Consistent with our previous data, more stalled mitochondria, OPTN, and LC3b puncta were observed in the axons expressing E50K OPTN compared to those expressing Wt OPTN, with relatively balanced populations of anterograde and retrograde movement in both Wt and E50K OPTN (analyzed per axon in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref> and analyzed per animal in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C’</xref>). Anterograde and retrograde velocities for mitochondria, OPTN, and LC3b in the sparsely labeled Wt and E50K OPTN axons also were similar to those measured in the whole nerves, and once again showed no significant differences in velocities after expression of E50K OPTN (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Of note, the diameter of axons based on the LC3b signal (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>) and the intensity of the LC3b signal (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>) were comparable after expression of Wt or E50K OPTN, validating the use of cytoplasmic LC3b-GFP as a suitable axon mask in both these sparse axon experiments and the previous whole nerve experiments. Consistent with the other sparse labeling results above, the amounts of mitochondria and OPTN outside of axons were higher than those previously measured. In the case of E50K OPTN, 35.8% of mitochondria and 21.8% of OPTN were determined to be outside of the axons in the sparse labeling experiments (as compared to 13.4% and 17.9%, respectively, measured in the whole nerves). The difference between whole nerve and sparsely labeled axons was far larger in the case of expression of Wt OPTN, where previously approximately 2.7% and 0.5% had been found for mitochondria and mito-OPTN, respectively (see <xref ref-type="fig" rid="fig3">Figure 3D, E</xref>), but now 15.2% of mitochondria and 5.7% of OPTN were shown to be outside of the RGC axons (<xref ref-type="fig" rid="fig4">Figure 4D, E</xref>); this order of magnitude difference in results is presumably due to nearly all the extra-axonal Mitotracker-labeled mitochondria and OPTN are found within the nerve parenchyma, not having reached high enough levels to be measurable on the surface of the optic nerve. Collectively, these data show that even in the case of expression of Wt OPTN, which we showed above does not alter the movement behavior of mitochondria within axons, there already is a substantial amount of both mitochondria and OPTN outside of the axons from which they derive, and that expression of E50K OPTN, in addition to resulting in the stalling of large number of mitochondria, OPTN, and LC3b within axons and co-localization of mitochondria and OPTN also significantly increase the amount of both OPTN and mitochondria that are found outside of the axons and further result in over an order of magnitude increase in how much mitochondria signal is found near the surface of the optic nerve.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Retinal ganglion cell (RGC) axonal mitochondria and OPTN found outside of the LC3b-labeled axons are both within the optic nerve parenchyma and on the surface of the optic nerve and are increased by expression of E50K OPTN.</title><p>(<bold>A</bold>,<bold> B</bold>) E50K OPTN from sparsely labeled axons found outside of LC3b-labeled axons is found both within the optic nerve parenchyma and at the optic nerve surface. (<bold>A</bold>) Reconstruction showing astrocyte membranes of the host, from <italic>Tg(Fabp7:mTagBFP2-Ras)</italic> here abbreviated as mBFP, and E50K OPTN and LC3b (merged images on the bottom) from the axons of the donor cells. D: dorsal, V: ventral, C: caudal, R: rostral. Scale bar, 10 µm. (<bold>B</bold>) Percentage of OPTN on the optic nerve surface (<italic>y</italic>-axis) versus percentage of total OPTN outside of the LC3b-labeled axons (<italic>x</italic>-axis). <italic>n</italic> = 11 animals. Trend line with 0.522 <italic>R</italic>-squared value. (<bold>C</bold>, <bold>E</bold>) Sparse labeling of axons reveals that extensive amounts of axonal mitochondria and OPTN are outside of the axons. (<bold>C</bold>) 3D reconstructions of sparsely labeled axons showing mitochondria and either Wt or E50K OPTN reveal much of both are outside the LC3b-labeled RGC axons (merged images on the bottom). D: dorsal, V: ventral, C: caudal, R: rostral. Scale bar, 10 µm. Percentage of mitochondria (<bold>D</bold>) and OPTN (<bold>E</bold>) outside the LC3b-labeled RGC axons in animals expressing Wt and E50K OPTN, respectively. Mean ± SEM; <italic>n</italic> = 9–10 animals. Statistical analysis in (<bold>D</bold>) and (<bold>E</bold>) was performed by unpaired, two-tailed Student’s <italic>t</italic>-test. *p &lt; 0.05, **p &lt; 0.01.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Movements of axonal mitochondria, OPTN, and LC3b within the sparsely labeled Mitotracker-labeled <italic>Tg(Isl2b:mCherry-OPTN(Wt or E50K)_ EGFP-LC3b)</italic> axons of retinal ganglion cells (RGCs) transplanted into non-transgenic <italic>X</italic>. <italic>laevis</italic>.</title><p>Representative confocal images (<bold>A</bold>) and corresponding kymographs (<bold>B</bold>) of axonal mitochondria and OPTN within the sparsely labeled axons. Scale bar, 10 µm. Relative to Wt OPTN, E50K OPTN increases the percentage of stationary mitochondria, OPTN, and LC3b measured in sparsely labeled axons (analyzed per axon (<bold>C</bold>) and per animal (<bold>C’</bold>)). Mean ± SEM; <italic>n</italic> = 228–383 mitochondria in 48–52 axons from 10 animals. <italic>n</italic> = 249–331 OPTN in 44–66 axons from 10 animals. <italic>n</italic> = 213–340 LC3b in 42–51 axons from 10 animals. (<bold>D</bold>) Average speed of axonal mitochondria, OPTN, and LC3b in each direction (anterograde and retrograde) in Wt and E50K OPTN transgenic animals. Mean ± SEM; <italic>n</italic> = 71–97 mitochondria in 48–52 axons from 10 animals. <italic>n</italic> = 61–93 OPTN in 44–66 axons from 10 animals. <italic>n</italic> = 28–95 LC3b in 42–51 axons from 10 animals. (<bold>E</bold>) Width measurement of axons based on the EGFP-LC3b signal after expression of Wt or E50K OPTN. Mean ± SD; <italic>n</italic> = 14 axons from 5 animals for Wt OPTN, and <italic>n</italic> = 6 axons from 3 animals for E50K OPTN. (<bold>F</bold>) Peak EGFP-LC3b signal per axon after expression of Wt or E50K OPTN, normalized relative to mean value of Wt OPTN group. Mean ± SD; <italic>n</italic> = 14 axons from 5 animals for Wt OPTN, and <italic>n</italic> = 6 axons from 3 animals for E50K OPTN. Statistical analyses in (<bold>C</bold>) and (<bold>D</bold>) were performed by two-way ANOVA following Tukey’s post hoc test for multiple comparisons, and in (<bold>E</bold>) and (<bold>F</bold>) by unpaired, two-tailed Student’s <italic>t</italic>-test. Not significant (ns); *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig4-figsupp1-v2.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-103844-fig4-video1.mp4" id="fig4video1"><label>Figure 4—video 1.</label><caption><title>Sparse axon labeling reveals additional OPTN outside of axons.</title><p>Sparse EGFPLC3b/mCherry-OPTN (E50K) axons in a Fabp7:mTagBFP2Ras host reveal OPTN signal within the nerve parenchyma as well as at the glial surface. Scale bar, 15 µm.</p></caption></media></fig-group></sec><sec id="s2-4"><title>Shed axonal mitochondria are degraded by astrocytes</title><p>To determine where outside axons the axonal mitochondria were degraded, we carried out correlated light EM analyses on sparsely labeled axons. First, cells from animals expressing a membrane-targeted mCherry transgene in RGCs were transplanted into animals expressing two different transgenes in astrocytes, the same membrane-associated BFP transgene used above to label all astrocyte membranes, and also an Aquaporin-4-GFP (Aqp4-GFP) fusion construct that labels principally the glial limitans at the surface of the optic nerve. One day after labeling the RGC axonal mitochondria through an intravitreal injection of Mitotracker Deep Red, the optic nerves of these animals were live-imaged in their entirety at lower <italic>x</italic>-, <italic>y</italic>-, and <italic>z</italic>-resolution for just the Aqp4-GFP transgene (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), and then one region imaged at higher resolution in all four channels (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). The heads of fixed animals, heavy metal processed and embedded in epoxy resin, were then analyzed by micro-CT in order to identify the same region that had been live imaged (<xref ref-type="fig" rid="fig5">Figure 5C</xref>) and then the full thickness of the optic nerve at that location was analyzed by serial block-face scanning electron microscopy (SBEM). After registering the live imaging and SBEM datasets based on the position of nuclei, some of the Mitotracker signal outside axons that had been live-imaged could be unambiguously identified at the level of EM. The axon-derived material on the surface of the optic nerve, in this case dye-labeled mitochondria and transgene-labeled axonal membranes, was determined to be within the soma of a transgene-labeled astrocyte (<xref ref-type="fig" rid="fig5">Figure 5D, E</xref>), and morphologically appeared as mitochondria and membranes at various stages of degradation. The mitochondria that live-imaging determined to be stationary within the nerve parenchyma were harder to unambiguously correlate between light and SBEM datasets, but those that could were determined to be within the fine processes of astrocytes (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). Notably, while axonal debris was most often observed within individual fine processes, and those processes were closely apposed to fine processes of distinct astrocytes (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). The soma of the astrocytes was located at the optic nerve periphery but had processes that extended deep into the parenchyma (<xref ref-type="fig" rid="fig5">Figure 5G</xref>), similar to astrocytes that surround axon bundles within larger mammalian optic nerves. Thus, it is possible that the axon-derived debris found within astrocyte soma at the surface of the optic nerve might have originated deep within the optic nerve parenchyma. However, it also may have originated near the astrocyte soma, as dystrophic axons with mitochondria undergoing early steps of mitophagy could also be observed within some axons in close contact with the astrocyte soma (<xref ref-type="fig" rid="fig5">Figure 5H, I</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Extruded axonal mitochondria are degraded by astrocytes.</title><p>(<bold>A</bold>) Z-projection of full length of the optic nerve visible through live imaging, labeled by an Aqp4-GFP transgene expressed in astrocytes. (<bold>B</bold>) Z-projections of four channels after higher resolution imaging of a region of the same optic nerve, position shown in stippled boxed region in (<bold>A</bold>); four channels are astrocyte expressed mem-BFP and Aqp4-GFP transgenes, a retinal ganglion cell (RGC) expressed mem-mCherry transgene, together with intravitreally injected Mitotracker. Solid boxes represent fields shown at higher resolution in (<bold>D</bold>) and (<bold>E</bold>). (<bold>C</bold>) Micro-CT of the head of the same animal after embedding in epoxy resin, used to pin-point the area live-imaged for subsequent SBEM analyses. Optic nerve is colorized green. Letter insets: e is eye and br is brain. (<bold>D</bold>) Superficial astrocyte soma labeled by astrocyte expressed Aqp4-GFP transgene (i) containing axonal derived membranes (ii) and mitochondria (iii). Arrow, arrowhead, and double arrows represent three discrete axonal mitochondria signal unambiguously identifiable at both light level live imaging and at the level of SBEM, shown in (<bold>E</bold>) and (<bold>F</bold>). (<bold>E</bold>) Two SBEM sections of the same astrocyte soma centered on discrete pockets phagocytosed axonal membranes and mitochondrial material. (<bold>F</bold>) Extra-axonal mitochondria and membranes within fine astrocyte processes. Asterisk represents a process originating from the same astrocyte shown in (<bold>G</bold>). (<bold>G</bold>) Morphology of one of the astrocytes whose processes are near the extra-axonal mitochondria shown in (<bold>F</bold>); on right, reconstruction of about half the astrocyte and on left single plane. (<bold>H</bold>) Reconstruction of an axon near the soma of the same astrocyte shown in (<bold>D</bold>) and (<bold>E</bold>). (<bold>I</bold>) Dystrophic mitochondria within axon appearing to be enwrapped in other axonal membranes within the axon, adjacent to superficial astrocyte soma.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig5-v2.tif"/></fig></sec><sec id="s2-5"><title>At least some OPTN and mitochondria leave RGC axons through focal axon dystrophies</title><p>To investigate how RGC axonal mitochondria and OPTN leave axons, we performed additional sparse labeling experiments. Live imaging of sparsely labeled axons in animals expressing both a membrane-targeted GFP (lyn-GFP) and a mitochondrial-targeted mCherry (Tom20-mCherry) transgene revealed extensive mitochondria signal outside of axons that was relatively unchanged over 10 min of imaging (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, and <xref ref-type="video" rid="fig6video1">Figure 6—video 1</xref>). In these nerves, 6.3 ± 0.1% (SD) of the Tom20-mCherry mitochondria signal was outside of the lyn-GFP-labeled axons, which is comparable to the measure of mitochondria outside sparse axons obtained based on Mitotracker labeling. Manual counting of Tom20-mCherry-labeled mitochondria within five discrete axon segments (100–150 µm in length) in two animals and Imaris-based semi-automatic counts within approximately 235 axon segments (75–175 µm in length) in 7 animals provided similar estimates for the frequency of stopped mitochondria, namely 3.8 ± 2.3 (SD) or 6.3 ± 5.0 (SD) per 100 µm of axon length, respectively. Among these sparsely labeled axons, there were also membranous asymmetric focal dystrophies, or protrusions, containing mitochondria similar in shape to what we previously described in the mouse optic nerve head (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). In the same axons where mitochondria number was counted, a total of 78 of such asymmetric dystrophies were found, thus representing 0.47 per 100 µm length of axon. However, of these protrusions, only 47, or 60.3%, contained mitochondria. Thus, approximately 1 in 20 stopped mitochondria within axons is contained within such protrusions. Of note, the mitochondria that were contained within these axonal protrusions were significantly more spherical than the average axonal mitochondria (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Tracking of 18 of these same mitochondria containing protrusions over approximately 8 min of repeated imaging every minute found 13 of them still present at the last time point, showing that these asymmetric mitochondria containing axonal dystrophies persist on average more than 5 min.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Mitochondria and OPTN leave retinal ganglion cell (RGC) axons through focal dystrophies.</title><p>(<bold>A</bold>) Tom20-mCherry-labeled RGC mitochondria from sparse axons are found outside the axons, as labeled by a membrane EGFP transgene. Image is a z-projection spanning 4 µm, as external mitochondria have a diffuse pattern. (<bold>B</bold>) Axolemmal protrusions in sparse axons containing mitochondria. Image represents a single z plane. (<bold>C</bold>) Sphericity measures show that mitochondria within axolemmal protrusions differ from other axonal mitochondria. (<bold>D</bold>) Examples of axonal dystrophies in sparsely labeled <italic>Tg(Isl2b:mCherry-OPTN(M98K)_ EGFP-LC3b)</italic> axons containing partially co-localized stopped OPTN and LC3b; presented as a pseudo-sequence consistent with extra-axonal OPTN being the product of transcellular mitochondrial degradation. (i) Swelling, where the mitophagy machinery OPTN and LC3b is stopped together and focally enriched in a symmetric axonal dystrophy. (ii) Loading, where focally accumulated OPTN is enriched in an asymmetric axonal dystrophy. (iii) Pinching-off, where an axon evulsion is acutely separated from the axon of origin and appears to coalesce with other extra-axonal OPTN presumably within acidified organelles of a phagocyte. Scale bar, 1 µm. (<bold>E</bold>) Changes in fluorescence within the axon protrusion and directly beneath it within the axon of origin suggest an active loading process. (<bold>F</bold>) Minimum distance and (<bold>F’</bold>) changes in fluorescence within the axon evulsion show further increase in OPTN soon after separation from the axon. Gray dotted horizontal lines represent the mean fluorescence in the same axon away from the axon dystrophy, set at 1; thus, all fluorescence values shown represent focal concentrations of both LC3b and OPTN signal, suggestive of these being sites of axonal mitophagy. (<bold>G</bold>) Dot-avoidance response of animals expressing OPTN Wt or E50K transgenes. Not significant (ns); ***p &lt; 0.0001 .</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103844-fig6-v2.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-103844-fig6-video1.mp4" id="fig6video1"><label>Figure 6—video 1.</label><caption><title>Loading of OPTN into axonal dystrophy.</title><p>Time-lapse (8 min) showing M98K OPTN accumulation in an asymmetric protrusion as EGFP‑LC3b levels decline in the adjoining axon. Scale bar, 1 μm.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-103844-fig6-video2.mp4" id="fig6video2"><label>Figure 6—video 2.</label><caption><title>Extruded mitochondria are static.</title><p>lyn‑GFP/Tom20‑mCherry imaging over 10 min shows extra‑axonal mitochondria remain stationary within the optic nerve parenchyma. Scale bar, 1 μm.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-103844-fig6-video3.mp4" id="fig6video3"><label>Figure 6—video 3.</label><caption><title>Dystrophy pinches off from axon.</title><p>Live imaging captures a mCherry-OPTN/EGFP-LC3b-marked dystrophy detaching from the M98K OPTN‑expressing retinal ganglion cell (RGC) axon. Scale bar, 1 μm.</p></caption></media></fig-group><p>In order to determine the localization of OPTN relative to these axonal dystrophies, we performed similar experiments where instead donors expressed LC3b-EGFP and OPTN-mCherry transgenes. Since transplants are challenging to perform and must be done before knowing whether the transplanted cells will express the transgenes, and the intermediates are short-lived, these studies were conducted mainly for axons expressing the glaucoma-associated M98K OPTN mutation, as these animals had the greatest number of stopped OPTN in both F0 and F1 analyses (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). After the repetitive z-scan live imaging of optic nerve sub-volumes, areas with focally increased LC3b and OPTN signal were digitally extracted and their position at different times registered, to measure shape and fluorescence intensity changes over time. Areas of increased LC3b and OPTN were found in four types of structures: symmetric axonal swellings with static LC3b and OPTN, asymmetric axonal dystrophies with static or changing levels of OPTN or LC3b, a small number of asymmetric axonal dystrophies that pinched off from axons during the imaging window, and structures with no connection to axons. An axonal ‘swelling’ is shown where the mitophagy machinery OPTN and LC3b are focally stopped and enriched together (<xref ref-type="fig" rid="fig6">Figure 6D, i</xref>). An asymmetric axon dystrophy is shown in what appears to be a ‘loading’ stage (<xref ref-type="fig" rid="fig6">Figure 6D, ii</xref> and <xref ref-type="video" rid="fig6video2">Figure 6—video 2</xref>). Here, the OPTN signal increases within the dystrophy simultaneously with a decrease in the OPTN signal immediately below the dystrophy within the associated axon, suggestive of an active loading process (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). The last example shown is a ‘pinching-off’ event where the axon dystrophy is physically detached from the axon of origin and appears to amalgamate with other areas of extra-axonal OPTN (<xref ref-type="fig" rid="fig6">Figure 6D, iii</xref> and <xref ref-type="video" rid="fig6video3">Figure 6—video 3</xref>). Minimum distance measures between the outer boundaries of protrusion/evulsion and axon of origin (<xref ref-type="fig" rid="fig6">Figure 6F</xref>) and measures of the distance from its centroid to the nearest position along the axon (not shown) demonstrate that the detachment process is acute, occurring within a 30-s interval. The shape, size, and dynamics in these focal asymmetric axonal dystrophies lead us to conclude that at least some of the OPTN and mitochondria leave the axons by the transcellular degradation process we first described in the mouse optic nerve head (<xref ref-type="bibr" rid="bib16">Davis et al., 2014</xref>). Finally, since the E50K OPTN mutation causes glaucoma, we then asked whether increased transcellular degradation might be associated with vision loss. For this, we used a behavior assay that reports RGC innervation of the optic tectum (<xref ref-type="bibr" rid="bib20">Dong et al., 2009</xref>), the main brain target for RGC axons and the equivalent of the mouse superior colliculus. Animals expressing Wt or E50K OPTN showed no measurable visual impairment 3 days after inducing transgene expression with doxycycline, the time at which E50K OPTN expression results in an increase in transcellular degradation of mitochondria.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>There is evidence that damaged axonal mitochondria are delivered back to or near the soma for degradation through OPTN-mediated mitophagy, although these studies were conducted mainly in cultured cells (<xref ref-type="bibr" rid="bib61">Moore and Holzbaur, 2016</xref>; <xref ref-type="bibr" rid="bib21">Evans and Holzbaur, 2020</xref>). Our studies in vivo are not inconsistent with this, as we did not image the retina where such degradation would be occurring; however, here we demonstrate that at least in tadpole optic nerves, large numbers of RGC axonal mitochondria are degraded within the optic nerve. We found that after expression of various mutated OPTNs, there are significant increases in the amount of OPTN and LC3b stopped within axons, and, in the one case we analyzed in most detail, the glaucoma-associated E50K mutation, also significant increases in the amount of stopped mitochondria, much of which is co-localized with OPTN. Arresting mitochondrial motility, which is mainly driven by degradation of the motor-adaptor protein Miro, is believed to be an early stage of mitophagy where dysfunctional mitochondria are stopped and sequestered for subsequent mitophagy through PINK1/Parkin-mediated pathway in both in vivo and in vitro settings (<xref ref-type="bibr" rid="bib93">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Liu et al., 2012</xref>; <xref ref-type="bibr" rid="bib48">Lovas and Wang, 2013</xref>; <xref ref-type="bibr" rid="bib3">Ashrafi et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Hsieh et al., 2016</xref>). Since we demonstrate that OPTN and mitochondria co-localize within the optic nerve, our data strongly support the view that some steps associated with mitophagy occur locally in RGC axons far from the cell body. We found that under basal conditions, about half of axonal mitochondria are stopped; many of these have an elongated morphology and likely represent those mitochondria providing energy and other functions locally needed to support diverse cellular processes, including but not limited to action potential regeneration. However, after perturbations as slight as the injection of a balanced salt solution into the eye, the population of axonal mitochondria that are stopped within axons increases. We believe that these are unlikely to be more mitochondria supporting functions normally associated with axonal mitochondria, but rather that this second stopped population of axonal mitochondria is undergoing a process that at the very least shares some molecular machinery with mitophagy. However, this process does not appear to be conventional axonal mitophagy because neither the number of axonal mitochondria nor the fraction of stopped mitochondria is affected by chloroquine treatment, and, most importantly, because the majority of axonal mitochondria appear to be degraded by a transcellular degradation process, likely the same one that we previously described in the optic nerve head and cerebral cortex of normal mice (<xref ref-type="bibr" rid="bib16">Davis et al., 2014</xref>).</p><p>The glaucoma-associated OPTN mutations not only had the largest fraction of stopped OPTN and LC3b within axons, but also led to large amounts of OPTN being found outside of the axons, some of which reached the surface of the optic nerve. Indeed, the studies based on sparse labeling of axons, which likely provide a more accurate estimate of the fraction of axonal mitochondria and OPTN outside of axons, suggest that the number of axonal mitochondria degraded outside of axons is large. After expression of Wt OPTN, which we believe represents the basal state as we also show that Wt OPTN expression has no effect on the behavior of axonal mitochondria, as much as 15.2 and 5.7% of the stopped mitochondria and OPTN, respectively, are outside of the axons, and in the case of expression of the E50K OPTN, those numbers increase to 35.8 and 21.8%. An independent measure that did not involve intravitreal injections, one based on a Tom20-mCherry transgene, provided a similar estimate of the fraction of axonal mitochondria outside of axons in the optic nerve, at 6.3%. However, all of these measures should be viewed as mere estimates, as the amounts of mitochondria outside of axons as determined by the Tom20-mCherry transgene differed some from those based on Mitotracker labeling, especially when accounting for the mitochondria signal found on the surface of the optic nerve. It is likely that the Mitotracker signal outside of axons represents only mitochondria that are still morphologically intact, whereas the mCherry signal associated with the Tom20 or OPTN fusion constructs is expected to persist longer due to the intrinsic stability of the mCherry protein, indeed probably longer than most endogenous mitochondrial proteins. This may explain why, in the baseline state, including after expression of Wt OPTN, there is so little Mitotracker label on the surface of the optic nerve. Taking this reasoning one step further raises the interesting possibility that in our system, the various OPTN mutations may be acting not only by increasing the targeting of mitochondria for degradation within the axons, which they seem to do as we observe increased co-localization of mitochondria and OPTN even within moving populations within axons, but also that the OPTN mutants may separately affect the degradation of mitochondria. Indeed, there is evidence that OPTN may participate in multiple stages of mitochondria degradation in addition to bridging ubiquitinated mitochondria and LC3b, including the beginning steps of autophagosome formation (<xref ref-type="bibr" rid="bib84">Song et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Evans and Holzbaur, 2020</xref>) but also, through its interaction with Myosin-VI, also the ultimate delivery of these cargo to lysosomes (<xref ref-type="bibr" rid="bib32">Hu et al., 2019</xref>). In our system, those later steps required for organelle degradation occur not within the RGC themselves but rather within astrocytes. Of note, in a co-culture model using ES-derived human RGCs and astrocytes, the E50K mutation in astrocytes was sufficient to cause neuronal dysfunction (<xref ref-type="bibr" rid="bib26">Gomes et al., 2022</xref>). Thus, some or all of the pathological activity of glaucoma-associated OPTN mutations may occur outside of the RGCs themselves.</p><p>Mitochondria and OPTN found outside of axons could have in principle been eliminated by any of the cells present in the optic nerve, either the astrocytes which constitute the major local population, other resident cells such as NG2-cells or microglia, or alternatively by invading myeloid cells, all of which are known to have phagocytic capacity. We had previously shown that in the frog optic nerve, it is astrocytes that are the major phagocytes that clear extensive amounts of axonal and myelin debris using well-conserved phagocytic machinery, at least during a developmental remodeling event (<xref ref-type="bibr" rid="bib56">Mills et al., 2015</xref>). Correlated light EM studies of sparsely labeled axons here demonstrate that the majority of these axonal material, including mitochondria, is here too degraded by the astrocytes, either in their fine processes that interdigitate deep in the nerve parenchyma, or far from the axons within the soma of the astrocytes, which in tadpoles at this stage reside exclusively on the surface of the optic nerve. The finding of large amounts of axonal mitochondria and OPTN on the surface of the optic nerve in astrocytes with prominent localization of an Aqp4-GFP reporter to their membranes is reminiscent of the glymphatic-like system that has been described in the mouse optic nerve (<xref ref-type="bibr" rid="bib95">Wang et al., 2020</xref>); thus, whether mitochondria debris is cleared by a glymphatic pathway maybe should be investigated. Curiously, the axonal debris accumulating on the surface of the optic nerve was not uniformly distributed but rather was found mainly on the dorsal side. Whether this is related to anatomical asymmetries within the nerve or in the location of structures outside the nerve, such as lymph nodes, or whether this is in any way related to asymmetries in axonal degeneration observed in glaucoma, are all unknown but may be worthy of further exploration.</p><p>One important question is how the axonal mitochondria and OPTN reach the outside of axons. While we cannot exclude the possibility that some of the axonal mitochondria signal outside axons might derive from axons that have previously degenerated, the axonal structures live-imaged in this study are highly similar in size and shape to the mitochondria-filled protrusions still attached to axons and mitochondria-filled evulsions separated from axons that we had described in the optic nerve head of wild-type mice through both a mitochondria-targeted tandem EGFP-mCherry reporter and SBEM (<xref ref-type="bibr" rid="bib16">Davis et al., 2014</xref>). Here, we provide evidence that one of twenty stopped axonal mitochondria, which is approximately one in fifty of all mitochondria within axons, is contained within a membranous protrusion, and the number that have recently pinched off is likely far higher.</p><p>Notably, the focal dystrophies which we observe on RGC axons are similar to what others refer to as exophers, both in <italic>Caenorhabditis elegans</italic> (<xref ref-type="bibr" rid="bib53">Melentijevic et al., 2017</xref>) and in mammalian cardiac tissue (<xref ref-type="bibr" rid="bib68">Nicolás-Ávila et al., 2020</xref>). In the case of exophers, the cellular extrusions occur constitutively, increase in response to various stressors, and contain diverse protein aggregates and dysfunctional organelles, which can but do not necessarily include mitochondria. In our case too, not all of the axonal protrusions contain mitochondria, but in those that did, the mitochondria were more spherical than the average axonal mitochondria, consistent with them being the product of mitochondria fission, quite possibly due to being damaged or dysfunctional. It may be that the other axonal protrusions that did not contain mitochondria contained other organelles or protein aggregates, though the possibility that the outpocketings form prior to mitochondria entering them cannot be formally excluded. In <italic>C. elegans</italic>, after the pinching off of the exophers, they are processed to smaller ‘starry night’ vesicular structures that likely represent the endolysosomal intermediates on the path to the eventual degradation by lysosomes (<xref ref-type="bibr" rid="bib96">Wang et al., 2023</xref>); it seems likely that the puncta containing axonal material that we observed within astrocyte processes and soma both at the light (e.g., <xref ref-type="video" rid="fig6video3">Figure 6—video 3</xref>) and at the EM level likely are the equivalent of these ‘starry night’. Thus, we suggest that axonal transcellular degradation of mitochondria, which we previously had also referred to as transmitophagy, is but an axonal variant of exopher generation that may have evolved as an alternative mechanism for long projection neurons such as RGCs to deal with more dysfunctional mitochondria or aggregates in distal regions of axons than could be dealt with by the more conventional cell-autonomous processes of somal or axonal mitophagy. What controls the balance between the cell-autonomous and non-cell-autonomous axonal degradation mechanisms remains an open question, although the control of mitochondria stalling, perhaps through the regulation of Miro stability by the PINK/Parkin pathway (<xref ref-type="bibr" rid="bib93">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Liu et al., 2012</xref>; <xref ref-type="bibr" rid="bib48">Lovas and Wang, 2013</xref>; <xref ref-type="bibr" rid="bib3">Ashrafi et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Hsieh et al., 2016</xref>), is a possibility worthy of further study.</p><p>While the OPTN mutations that result in maximal transcellular degradation of RGC axon mitochondria are the very same mutations that in humans cause glaucoma, our study does not address whether increased transcellular degradation may in any way be relevant to the RGC axonal degeneration that defines this disease. At the time that our live-imaging studies were carried out, the tadpoles expressing the glaucoma-associated OPTN mutation did not show any obvious vision impairment, though that was after only 3 days after first inducing transgene expression. Whether more prolonged expression of these OPTN mutants will affect vision is yet to be determined. If they do not, it may be hard to interpret, as tadpoles of this stage have the ability to regenerate their axons and regain vision within days of all their axons being damaged (<xref ref-type="bibr" rid="bib22">Fague and Marsh-Armstrong, 2023</xref>). However, a recent study in mouse optic nerve head (<xref ref-type="bibr" rid="bib108">Zhu et al., 2023</xref>) where axonal mitochondria were labeled by Mitotracker retrograde transport found that the axonal Mitotracker signal within astrocytes increased in mice where intraocular pressure was elevated by microbead injection into the anterior chamber, an experimental paradigm used to model glaucoma. Further, they found that the Mitotracker signal was found largely within the distended processes of astrocytes that express high levels of Lgals3, the gene whose expression in astrocytes initially led us to the discovery of the transcellular degradation process, and which we had also shown increases in a different glaucoma model, DBA2/J mice (<xref ref-type="bibr" rid="bib67">Nguyen et al., 2011</xref>). If an increase in transcellular axonal mitochondria degradation does contribute to glaucoma, a likely pathogenic mechanism might be inflammation resultant from the accumulation of immunogenic mitochondria debris outside of the axons, as that was shown to result when the clearance of mammalian cardiac exophers was blocked by removal of a phagocytic receptor (<xref ref-type="bibr" rid="bib68">Nicolás-Ávila et al., 2020</xref>). Regardless of whether or not transcellular degradation of mitochondria contributes to the etiology of glaucoma, such a system might be a mechanism to handle the accumulation of detrimental aggregates and damaged organelles within diverse axons, which would be of obvious relevance to a variety of neurodegenerative disorders that affect axonal biology early in their progression.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Transgenes</title><list list-type="bullet" id="list1"><list-item><p>pCS2(Isl2b):rtTA2_pTRETightBI_mCherry-OPTNs_EGFP-LC3b: mCherry flanked by additional restriction sites was amplified from pTRETightBI-RY-0 (Addgene plasmid # 31463; <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene">http://n2t.net/addgene</ext-link>:31463; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_31463">Addgene_31463</ext-link>) (<xref ref-type="bibr" rid="bib64">Mukherji et al., 2011</xref>) using CD160 and CD161 and recloned into XmaI and EcoRV sites of the same vector. Full-length human OPTN, from the Mammalian Gene Collection (CloneID 3457195, purchased from OpenBiosystems) was amplified with CD162 and CD163 and placed into MluI and EcoRV sites, creating pTRETightBI:mCherry-OPTN_NLS-EYFP. The β-globin polyadenylation sequence was then amplified from AAV2:MitoEGFPmCherry (<xref ref-type="bibr" rid="bib16">Davis et al., 2014</xref>) using CD60 and CD61 and inserted in between EcoRV and AatII sites downstream of OPTN. To make the EGFP-LC3b part of the constructs, the Egfp was first amplified from pCS2:mito-EGFP-mCherry (<xref ref-type="bibr" rid="bib16">Davis et al., 2014</xref>) using CD53 and CD91h and cloned into pTRETight:MitoTimer (Addgene plasmid # 50547; <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene">http://n2t.net/addgene</ext-link>:50547; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_50547">Addgene_50547</ext-link>) (<xref ref-type="bibr" rid="bib29">Hernandez et al., 2013</xref>), with EcoRI and XbaI, creating the construct pTRETight:EGFP. Then, full-length mouse LC3b from OpenBiosystems (CloneID 5319360) was amplified with CD58 and CD59 and cloned into SalI-NheI sites of this construct in order to make pTRETight:EGFP-LC3b. Then, EGFP-LC3b was moved into the previously created pTRETightBI:mCherry-OPTN_NLS-EYFP by cloning it into the EcoRI and XbaI sites, thus replacing the NLS-EYFP. In order to put both EGFP-LC3b and mCherry-OPTN under inducible control, the first step was to create a version of pCS2:rtTA2, previously shown to have low baseline and high inducibility in transgenic <italic>X. laevis</italic> (<xref ref-type="bibr" rid="bib15">Das and Brown, 2004</xref>; <xref ref-type="bibr" rid="bib56">Mills et al., 2015</xref>), but with an additional multiple cloning site to facilitate assembly. The rtTA2 itself was amplified from Blbp:rtTA2 (<xref ref-type="bibr" rid="bib56">Mills et al., 2015</xref>) using CD158 and CD159, and cloned into PmeI and PacI sites of a version of pCS2 vector where the CMV promoter had been previously replaced by 600 bp upstream sequences of the Cardiac Actin promoter (as well as a multiple cloning site or MCS containing ZraI, AatII, PmeI, and PacI restriction sites), accomplished by amplifying the promoter itself from <italic>X. laevis</italic> genomic DNA using CD156 and CD157. Then, the majority of pTRETightBI:mCherry-OPTN_EGFP-LC3b, excluding the backbone sequences, was placed between the AatII-NotI sites of this pCS2(MCS-CA600):rtTA2, before removing the CA600 promoter itself by digestion with PacI and NotI followed by blunting and self-ligation. pCS2(MCS):rtTA2_pTRETightBI:mCherry-OPTN_EGFP-LC3b was then cut with SalI and ZraI, and most of it moved into the SmaI and XhoI sites of a derivative of the previous pCS2 (1 kb Isl2b) vector containing both 1 kb of the RGC-specific Isl2b promoter as well a Flip-recombinase excisable Kanamycin antibiotic selection cassette (pCS2(1 kb Isl2b):GFP3-Frt-Kan-Frt; <xref ref-type="bibr" rid="bib97">Watson et al., 2012</xref>), into which a SmaI restriction site had been previously added immediately downstream of HindIII, so as to generate pCS2(1 kb Isl2b):rtTA2_pTRETightBI:mCherry-OPTN_EGFP-LC3b_FKF. All the OPTN mutations (E50K, M98K, F178A, D474N, E478G, and H486R) were then introduced into this construct by QuikChange Site-Directed Mutagenesis Kit (Stratagene) using the corresponding primers (Primer List below, mutagenized bases are shown in uppercase) and verified by Sanger sequencing. The final step of placing all these under control of the full 20 kb of the zebrafish Isl2b promoter, which drives RGC-specific expression in both zebrafish (<xref ref-type="bibr" rid="bib74">Pittman et al., 2008</xref>) and <italic>X. laevis</italic> (<xref ref-type="bibr" rid="bib97">Watson et al., 2012</xref>), was accomplished by recombineering as previously described (<xref ref-type="bibr" rid="bib97">Watson et al., 2012</xref>).</p></list-item><list-item><p>pCS2(Isl2b:Tom20-mCherry-Apex2_msSOD2UTR): First, to improve the mitochondria targeting efficiency of our original mitochondria transcellular degradation reporter, pCS2(1 kb Isl2b):Mito-EGFP-mCherry (<xref ref-type="bibr" rid="bib16">Davis et al., 2014</xref>), the SV40pA was replaced by the 3′UTR of msSOD2 (<xref ref-type="bibr" rid="bib35">Kaltimbacher et al., 2006</xref>) amplified from mouse brain cDNA (Clontech 637301) using primers AA35 and AA36 and inserted into the XbaI and NotI sites. Then, the mitochondria targeting sequence from Cox8 in this construct was replaced first by Sncg amplified from the same mouse brain cDNA with AA41 and AA42, using HindIII and BamHI, and from there replaced again by the mouse Tom20 sequences amplified from the same mouse brain cDNA with AA47 and AA48, using XmaI and BamHI. To make the Tom20-linker-mCherry-linker-FlagApex2-msSOD2UTR, all relevant fragments were combined in a four-way Gibson Assembly using the following primers: CD410 and CD621 (Fragment 1), CD620 and CD622 (Fragment 2), CD623 and CD627 (Fragment 3), and CD626 and CD411 (Fragment 4). This construct was originally made to contain within the first fragment a <italic>Xenopus</italic> Rhodopsin promoter (<italic>xop</italic>; <xref ref-type="bibr" rid="bib106">Zhang et al., 2008</xref>), but then the entire cDNA along with the polyadenylation sequence was moved with HindIII and NotI into a construct with 1 kb of the zebrafish-derived Isl2b promoter and Kanamycin selection cassette, so as to make the final construct, referred to simply as Isl2b:Tom20-mcherry in the text, by recombineering as described above.</p></list-item><list-item><p>pCS2(xtFapb7):mTagBFP2-Ras: BFP from pBAD-mTagBFP2 (Addgene plasmid # 34632; <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene">http://n2t.net/addgene</ext-link>:34632; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_34632">Addgene_34632</ext-link>) (<xref ref-type="bibr" rid="bib89">Subach et al., 2011</xref>), was amplified using FK99 and FK98 and cloned into HindIII and BglII sites of a pCS2 vector. The oligonucleotides encoding BglII-Ras farnesylation sequence (<named-content content-type="sequence">AAGCTGAACCCTCCTGATGAGAGTGGCCCCGGCTGCATGAGCTGCAAGTGTGTGCTCTCCTGA</named-content>) -XbaI was inserted into BglII and XbaI sites of the vector by using complementary oligonucleotides. Then the full cDNA of mTagBFP2-Ras and SV40 polyadenylation sequence was placed in between HindIII and NotI sites of pCS2(xtFabp7) vector.</p></list-item><list-item><p>pCS2(xtFapb7):xlAqp4-GFP: A Aqp4 cDNA was amplified from tadpole optic nerve mRNA using primers NMD18 and NMD20 and cloned into HindIII and NheI sites of a pCS2(xtFabp7) construct (<xref ref-type="bibr" rid="bib56">Mills et al., 2015</xref>) with a unique NheI site in frame upstream of GFP. This DNA was then used as template for PCR reactions using NMD 29 and CD411, and NMD30 and CD410. In order to mutagenize the first stop codon of Aqp4 into a tryptophan through a Gibson ligation of the two amplicons.</p></list-item><list-item><p>pCS2(xtFapb7):EGFP-mCherry-Lc3b: First, pCS2(xtFapb7):EGFP-Lc3b was made by amplifying the same mouse Lc3b as above with EM284 and EM285 and after digestion with NheI and XhoI cloning it into a construct carrying the same pCS2(xtFabp7) backbone as above digested with the same enzymes. Then, the EGFP-mCherry cassette was amplified from Mito-EGFP-mCherry (<xref ref-type="bibr" rid="bib16">Davis et al., 2014</xref>) using EM232 and EM339 and after digestion with HindIII and XbaI cloned into the HindIII and SpeI sites of pCS2(xtFapb7): EGFP-LC3b.</p></list-item></list><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">ID</th><th align="left" valign="bottom">Sequence</th><th align="left" valign="bottom">Gene</th><th align="left" valign="bottom">Forward/Reverse</th></tr></thead><tbody><tr><td align="left" valign="bottom">AA 35</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgtctagaactcacggccacattgagtg</named-content></td><td align="left" valign="bottom">msSOD2UTR</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">AA 36</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacggcggccgctggtgtactgtgaaactgtgacc</named-content></td><td align="left" valign="bottom">msSOD2UTR</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">AA 41</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgaagcttcccggggccaccatggacgtcttcaagaaaggcttc</named-content></td><td align="left" valign="bottom">msSncg</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">AA 42</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgggatccactagtgtcttctccactcttggcctctt</named-content></td><td align="left" valign="bottom">msSncg</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">AA 47</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgcccggggccaccatggtgggccggaacagcgcc</named-content></td><td align="left" valign="bottom">msTom20</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">AA 48</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgggatccttccacatcatcttcagccaagct</named-content></td><td align="left" valign="bottom">msTom20</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 19</td><td align="left" valign="bottom"><named-content content-type="sequence">gcagatgaaagagctcctgaccAAGaaccaccagctgaaagaagc</named-content></td><td align="left" valign="bottom">huOptn E50K</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 20</td><td align="left" valign="bottom"><named-content content-type="sequence">gcttctttcagctggtggttCTTggtcaggagctctttcatctgc</named-content></td><td align="left" valign="bottom">huOptn E50K</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 21</td><td align="left" valign="bottom"><named-content content-type="sequence">ctgttctgattttcatgctGGAagagcagcgagagagaaaattc</named-content></td><td align="left" valign="bottom">huOptn E478G</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 22</td><td align="left" valign="bottom"><named-content content-type="sequence">gaattttctctctcgctgctctTCCagcatgaaaatcagaacag</named-content></td><td align="left" valign="bottom">huOptn E478G</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 23</td><td align="left" valign="bottom"><named-content content-type="sequence">gcggctcctcagaagattccGCTgttgaaattaggatggc</named-content></td><td align="left" valign="bottom">huOptn F178A</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 24</td><td align="left" valign="bottom"><named-content content-type="sequence">gccatcctaatttcaacAGCggaatcttctgaggagccgc</named-content></td><td align="left" valign="bottom">huOptn F178A</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 25</td><td align="left" valign="bottom"><named-content content-type="sequence">gcagcgagagagaaaattCGTgaggaaaaggagcaactggc</named-content></td><td align="left" valign="bottom">huOptn H486R</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 26</td><td align="left" valign="bottom"><named-content content-type="sequence">gccagttgctccttttcctcACGaattttctctctcgctgc</named-content></td><td align="left" valign="bottom">huOptn H486R</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 53</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacggaattcaagcttgccaccatggtgagcaagggcgaggagctg</named-content></td><td align="left" valign="bottom">EcoRI-HindIII-Kozak-Egfp</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 58</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacggctagcccgtccgagaagaccttcaagc</named-content></td><td align="left" valign="bottom">NheI-msLC3b</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 59</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacggtcgacttacacagccattgctgtcccg</named-content></td><td align="left" valign="bottom">msLC3b-SalI</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 60</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacggtcgacgatatcgctagcctgaggatccgatctttttccc</named-content></td><td align="left" valign="bottom">SalI-EcoRV-NheI-βGlobin pA</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 61</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacggacgtctagggataacagggtaatgcggccgcc ttccgagtgagagacacaaaa</named-content></td><td align="left" valign="bottom">AatII-ISceI-NotI- βGlobin pA</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 91h</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgtctagagtcgacttaattaagctagccttgtacagctcgtccatgccga</named-content></td><td align="left" valign="bottom">Egfp-NheI-PacI-SalI-XbaI</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 156</td><td align="left" valign="bottom"><named-content content-type="sequence">acggtcgacgacgtcacctggtgtttaaacttaa</named-content><break/><named-content content-type="sequence">ttaatccactgcattctgtcctgaga</named-content></td><td align="left" valign="bottom">SalI-AatII-DraIII-SexAI-PmeI-PacI-CA promoter 600</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 157</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgaagctttggggactgagctgtcaatttata</named-content></td><td align="left" valign="bottom">HindIII-CA promoter 600</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 158</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacggtttaaacgccaccatgtctagactggacaagagcaaag</named-content></td><td align="left" valign="bottom">PmeI-rtTA2</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 159</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgttaattaagaattaaaaaacctcccacacctc</named-content></td><td align="left" valign="bottom">PacI-SV40pA</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 160</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgcccggggccaccatggtgagcaagggcgaggaggat</named-content></td><td align="left" valign="bottom">XmaI-Kozak-ATG-mCherry</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 161</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacggatatccgtcgtacgcgtcttgtacagctcgtccatgccg</named-content></td><td align="left" valign="bottom">mCherry-noSTOP-MluI-EcoRV</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 162</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgacgcgttcccatcaacctctcagctgcc</named-content></td><td align="left" valign="bottom">MluI-noATG-huOPTN</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 163</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacggatatcctaaatgatgcaatccatcacgtgaatc</named-content></td><td align="left" valign="bottom">huOPTN-EcoRV</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 177</td><td align="left" valign="bottom"><named-content content-type="sequence">agaagcaaaagagcgtctaAAGgccttgagtcatgagaatg</named-content></td><td align="left" valign="bottom">huOptn M98K</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 178</td><td align="left" valign="bottom"><named-content content-type="sequence">cattctcatgactcaaggcCTTtagacgctcttttgcttct</named-content></td><td align="left" valign="bottom">huOptn M98K</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 265</td><td align="left" valign="bottom"><named-content content-type="sequence">agatggaagtttactgttctAATtttcatgctgaaagagca</named-content></td><td align="left" valign="bottom">huOptn D474N</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 266</td><td align="left" valign="bottom"><named-content content-type="sequence">tgctctttcagcatgaaaATTagaacagtaaacttccatct</named-content></td><td align="left" valign="bottom">huOptn D474N</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 410</td><td align="left" valign="bottom"><named-content content-type="sequence">ggcatcgtggtgtcacgctcg</named-content></td><td align="left" valign="bottom">AmpR</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 411</td><td align="left" valign="bottom"><named-content content-type="sequence">cgagcgtgacaccacgatgcc</named-content></td><td align="left" valign="bottom">AmpR</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 620</td><td align="left" valign="bottom"><named-content content-type="sequence">ggacctggaagtattgctaccagaattcaaatggtgagcaagggcgaggaggat</named-content></td><td align="left" valign="bottom">Tom20-linker-mCherry</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 621</td><td align="left" valign="bottom"><named-content content-type="sequence">atcctcctcgcccttgctcaccatttgaattctggtagcaatacttccaggtcc</named-content></td><td align="left" valign="bottom">Tom20-linker-mCherry</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 622</td><td align="left" valign="bottom"><named-content content-type="sequence">gctagcgcctccgccagagcctccgcctccacgcgtcttgtacagctcgtccatgccg</named-content></td><td align="left" valign="bottom">mCherry- Glycine- linker</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">CD 623</td><td align="left" valign="bottom"><named-content content-type="sequence">acgcgtggaggcggaggctctggcggaggcgctagcatggactacaaggatgacgacg</named-content></td><td align="left" valign="bottom">Glycine-linker- FlagAPEX2</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 626</td><td align="left" valign="bottom"><named-content content-type="sequence">ggagcgcctgaccctggactaactcgagcctctagaactcacggccacatt</named-content></td><td align="left" valign="bottom">APEX2 msSOD2UTR</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">CD 627</td><td align="left" valign="bottom"><named-content content-type="sequence">aatgtggccgtgagttctagaggctcgagttagtccagggtcaggcgctcc</named-content></td><td align="left" valign="bottom">APEX2 msSOD2UTR</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">EM 232</td><td align="left" valign="bottom"><named-content content-type="sequence">aaggagaagcttgccaccatggtgagcaagggcgaggagc</named-content></td><td align="left" valign="bottom">EGFP-mCherry</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">EM 284</td><td align="left" valign="bottom"><named-content content-type="sequence">aaggaggctagcccgtccgagaagaccttcaag</named-content></td><td align="left" valign="bottom">msLC3b</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">EM 285</td><td align="left" valign="bottom"><named-content content-type="sequence">aaggagctcgagttacacagccattgctgtccc</named-content></td><td align="left" valign="bottom">msLC3b</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">EM 339</td><td align="left" valign="bottom"><named-content content-type="sequence">aaggagtctagacttgtacagctcgtccatgc</named-content></td><td align="left" valign="bottom">EGFP-mCherry</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">FK 99</td><td align="left" valign="bottom"><named-content content-type="sequence">aaggagaagcttgccaccatgagcgagctgattaaggag</named-content></td><td align="left" valign="bottom">Kozak-HindIII- BFP</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">FK 98</td><td align="left" valign="bottom"><named-content content-type="sequence">acgacgagatctatttagcttgtgccccagtttgctaggg</named-content></td><td align="left" valign="bottom">BFP-BglII</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">NMD 18</td><td align="left" valign="bottom"><named-content content-type="sequence">aaggagaagcttgccaccatggtggcatgtaaaggagtctgg</named-content></td><td align="left" valign="bottom">HindIII-xlAqp4</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">NMD 19</td><td align="left" valign="bottom"><named-content content-type="sequence">aaggagctcgagcaatatatctgtctcttttactggaag</named-content></td><td align="left" valign="bottom">XhoI-xlAqp4 (no stop 2)</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">NMD 20</td><td align="left" valign="bottom"><named-content content-type="sequence">aaggaggctagccaatatatctgtctcttttactggaag</named-content></td><td align="left" valign="bottom">NheI-xlAqp4 (no stop 2)</td><td align="left" valign="bottom">Reverse</td></tr><tr><td align="left" valign="bottom">NMD 29</td><td align="left" valign="bottom"><named-content content-type="sequence">ggtattatcttcggtatgGctagaagaaagaaatg</named-content></td><td align="left" valign="bottom">Aqp4 stop -&gt;Ala</td><td align="left" valign="bottom">Forward</td></tr><tr><td align="left" valign="bottom">NMD 30</td><td align="left" valign="bottom"><named-content content-type="sequence">catttctttcttctagCcataccgaagataatacc</named-content></td><td align="left" valign="bottom">Aqp4 stop -&gt;Ala</td><td align="left" valign="bottom">Reverse</td></tr></tbody></table></table-wrap></sec><sec id="s4-2"><title>Transgenesis and chloroquine treatment</title><p>Transgenic <italic>X. laevis</italic> were generated by REMI transgenesis (<xref ref-type="bibr" rid="bib1">Amaya and Kroll, 1999</xref>) using optimizations for larger DNA constructs that have been described previously (<xref ref-type="bibr" rid="bib56">Mills et al., 2015</xref>). In all cases, DNAs were linearized overnight with NotI in the injection buffer, followed by 65°C 20-min inactivation of the enzyme. Embryos were kept in 0.1X Marc’s Modified Ringer’s (MMR) with 50 μg/ml of gentamicin in sterile glass Petri dishes for the first 2 days, the first day at 16°C and the second at room temperature, and then subsequently kept in 0.1X MMR in glass bowls at room temperature and under a 12/12 light/dark cycle.</p><p>Animals were treated with 100 µM chloroquine diphosphate dissolved in 0.1X MMR for either 10 hr in the case of the measurements of autophagosomes with the <italic>pCS2(xtFapb7):LC3b-EGFP-mCherry</italic> transgene, and for 24 hr in the case of measurements of mitochondria movement within axons and amount of mitochondria signal outside axons.</p></sec><sec id="s4-3"><title>Generation of optic nerves with sparsely labeled axons</title><p>Approximately 10–50 eye anlage cells were surgically transferred from <italic>X. laevis</italic> homozygous or heterozygous for Isl2b:mCherry-OPTN(Wt/E50K/M98K)_EGFP-LC3b into either wild-type or <italic>Tg(xtFabp7:mTagBFP2-Ras)</italic> hosts at a developmental stage prior to retinal cell differentiation (at between NF stage 24 and 32). Surgeries were carried under Zeiss Stemi 2000 stereomicroscopes using hand-held curved tungsten micropins on animals anesthetized with 0.2 g/l of Tricaine Methanesulfonate (MS-222) in filter sterilized 0.1X MMR containing 50 μg/ml of gentamicin and with additional buffering provided by 2 mM HEPES, pH 7.4–7.6, in 35 mm Petri dishes. Animals were immobilized during surgeries in disposable clay-mold (Permoplast, non-toxic) inserts with adjacent grooves created with a pipette tip and then altered with forceps to loosely anchor donors and hosts in parallel near each other. At approximately 10 min after transplantation, the animals were released from their clay-mold enclosures and donors and hosts returned together to the same dish containing fresh sterile-filtered 0.1X MMR 2 mM HEPES with 50 μg/ml of gentamicin. Successful transplants, which were approximately half of the number of operations performed, were defined as those with donors confirmed as transgenic (since operations are done prior to onset of transgene expression), and whose hosts had eyes of normal size and only a few RGC axons labeled, as primarily assessed under a Leica MZ10F fluorescence-equipped stereomicroscope and then verified through confocal live-imaging (see details below).</p></sec><sec id="s4-4"><title>Intravitreal injection of mitotracker</title><p>Mitotracker Deep Red is a far-red fluorescent dye that chemically stains mitochondria in live cells (<xref ref-type="bibr" rid="bib5">Audano et al., 2021</xref>; <xref ref-type="bibr" rid="bib98">Weiss-Sadan et al., 2019</xref>). Fresh 200 µM of MitoTracker Deep Red FM (Cell Signaling Technology, #8778) dye solution was prepared by diluting a 5 mM of stock solution prepared in DMSO with filtered 0.5X MMR on the day of injection. The Mitotracker solution was front-loaded into a borosilicate glass capillary (World Precision Instruments) that had been pulled and then broken to 1–2 µm tip diameter using fine forceps, and then injected intravitreally into left eyes of anesthetized animals at around NF stage 48 (<xref ref-type="bibr" rid="bib70">Nieuwkoop and Faber, 1994</xref>), using a pressure injector (Narishige IM-300 Microinjector); successful injections were verified by observing an acute but mild swelling of the eye at the time of injection. After injection, the animals were returned to a new dish containing 0.1X MMR at room temperature and imaged 3.5 hr after injection for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref> and 15–18 hr after injection for all the other experiments.</p></sec><sec id="s4-5"><title>Optic nerve live imaging</title><p>In the case of doxycycline-inducible transgenes, <italic>X. laevis</italic> tadpoles were placed in 0.1X MMR with 50 μg/ml of doxycycline for 2–3 days before imaging. At around NF stage 48, <italic>X. laevis</italic> tadpoles were anesthetized in 0.1X MMR with 0.2 g/l of MS-222 and mounted into custom Sylgard 184 silicone elastomer (World Precision Instruments) molds. Molds were created using glutaraldehyde-fixed tadpoles at the same stages slightly angled using insect pin inserts so as to make left optic nerves parallel to the imaging plane, and then modified with surgical blades to provide an opening before the mouth to facilitate breathing. Tadpoles immobilized in the molds were weighed down by an 18 mm circular coverslip and imaged from beneath in a 35 mm dish modified with a 22 mm square glass coverslip as bottom. Optic nerves of the animals were imaged by spinning disk confocal microscopy (Dragonfly 503 multimodal imaging system, Andor Technology, Belfast, UK) with a ×40/1.10 (magnification/numerical aperture) HC PL APO water immersion objective, using a Leica DMi8 inverted microscope (Leica, Wetzlar, Germany), an iXon Ultra 888 EMCCD camera (Andor Technology, Belfast, UK), Fusion Software (Andor Technology, Belfast, UK) and laser lines of 100 mW 405 nm, 50 mW 488 nm, 50 mW 561 nm, and 100 mW 643 nm; first, a time-series was obtained at a single focal plane imaged for 1 min at 1 Hz, and the entire thickness of the nerve at that same location was z-scanned at 1 µm steps. Videos at 7 fps and images were created using FIJI ImageJ.</p><p>For some sparsely labeled axons, 5–10 µm thick regions of the optic nerve were subjected to repetitive z-scan live-imaging either at 30-s intervals for 5 min or at 2-min intervals for 10 min. Acquired images were saved as separate image sequence files using FIJI ImageJ and imported into IPLab software (Scanalytics). Regions of interest sampled at different time points were then registered and quantified using a macro written in IPLab. All the relevant videos (3 fps for M98K and 1 fps for E50K videos) and images were created using FIJI ImageJ.</p></sec><sec id="s4-6"><title>Kymograph analyses</title><p>Axonal movements of mitochondria, OPTN and LC3b: acquired time-series images were saved as separate image sequence files in FIJI ImageJ after being processed by HyperStackReg or StackReg Plugin to eliminate object drift. The aligned image sequence files were restacked using IPLab software, followed by either manual (for the sparsely labeled axons and curved axons) or semi-automatic tracing using IPLab macros so as to visualize and measure fluorescence intensity changes over time in the form of kymographs. For the semi-automatic tracings, the outer contour of the optic nerve was traced, and the approximately 30 µm diameter nerve was automatically divided into 0.9–1.8 µm parallel swaths, which contained small stretches of axons running in parallel; using such sampling distance and thickness, the same moving objects within axons were not multiply counted, but some of the larger immotile objects might have been multiply counted. Since there was high concordance between ratios of moving and static objects and the velocities of the moving objects when comparing whole-nerve semi-automatic kymographs and the more conventional single axon tracing used in the sparse labeling experiments, any error introduced by the novel semi-automatic tracing of axons was deemed minimal. Axonal movement was determined by counting the percentage of moving and stopped objects and measuring the speed of moving over the 1 min imaging period. Objects were classified as moving if their velocity was 0.1 μm/s or faster. Ratios and average speeds were calculated in Excel.</p><p>Co-localization measures: The same aligned and stacked images from the analysis of axonal movements were reprocessed and analyzed by a separate co-localization script but by the same logic through IPLab as described previously, except displaying multiple-channel fluorescence images along the merged color images, and sequentially tracing objects labeled by multiple fluorophores first, followed by those labeled by individual fluorophores. Ratios and average speeds were calculated in Excel.</p></sec><sec id="s4-7"><title>Nerve 3D reconstruction and quantification in Imaris</title><p>Z-scan confocal images of optic nerves expressing mCherry-OPTN and EGFP-LC3b were imported into Imaris software (Bitplane). Because LC3b is localized not only in autophagosomal membrane, but also is observed more diffusely within cytosol, including axoplasm (<xref ref-type="bibr" rid="bib25">Fu et al., 2014</xref>; <xref ref-type="bibr" rid="bib101">Wong and Holzbaur, 2014b</xref>; <xref ref-type="bibr" rid="bib91">Tammineni et al., 2017</xref>; <xref ref-type="bibr" rid="bib87">Stavoe et al., 2019</xref>; <xref ref-type="bibr" rid="bib21">Evans and Holzbaur, 2020</xref>; <xref ref-type="bibr" rid="bib40">Kuijpers et al., 2021</xref>; <xref ref-type="bibr" rid="bib6">Boecker et al., 2021</xref>), this EGFP-LC3b signal was used to create a mask to define the boundary of the RGC axons and to separately measure the mCherry-OPTN or far-red mitochondria signal that co-localized or not with the axons. The Imaris mask toolset was used to produce channels for OPTN, mitochondria, or OPTN–mitochondria either co-localizing or not with LC3b. The % outside axon values were calculated in Excel by comparing the volumes of objects outside of the LC3b mask relative to the total volumes.</p></sec><sec id="s4-8"><title>Correlated light SBEM</title><p>After optic nerve live imaging, tadpoles were fixed overnight with 4% paraformaldehyde, re-imaged for confocal imaging and positioning, then fixed overnight with 2% EM grade glutaraldehyde (18426, Ted Pella Incorporated) in 0.15 M sodium cacodylate buffer (SCB) containing 2 mM CaCl<sub>2</sub>. The tadpoles were then prepared for serial block-face imaging (SBEM) as described previously (<xref ref-type="bibr" rid="bib18">Deerinck et al., 2010</xref>). Briefly, tadpoles were washed with SCB then incubated in 2% OsO<sub>4</sub> + 1.5% potassium ferrocyanide in SCB containing 2 mM CaCl<sub>2</sub> for 1 hr. Tadpoles were washed with double distilled water (ddH<sub>2</sub>O) and incubated in 0.05% thiocarbohydrazide for 30 min. Tadpoles were then washed again with ddH<sub>2</sub>O and stained with 2% aqueous OsO<sub>4</sub> for 30 min. Tadpoles were again washed in ddH<sub>2</sub>O and placed in 2% aqueous uranyl acetate overnight at 4°C. Tadpoles were washed again with ddH<sub>2</sub>O and stained with en bloc lead aspartate for 30 min at 60°C. After a last wash in ddH<sub>2</sub>O, tadpoles were dehydrated on ice in 50%, 70%, 90%, and 100% ethanol solutions for 10 min each, followed by two 10-min incubations in dry acetone. Tadpoles were placed in 50:50 dry acetone/Durcopan resin overnight, followed by three changes of 100% Durcopan for ~12 hr each. Tadpoles were then allowed to harden in Durcopan at 60°C for 48 hr.</p><p>Tissue blocks were cut from hardened Durcopan, and the whole head of the tadpole was mounted on plastic dummy blocks, trimmed down to only the region surrounding the left optic nerve, eye, and brain. Exact location of optic nerve and the rest of the region of interest determined by X-ray microscopy imaging of tissue blocks performed on a Zeiss Xradia Versa 510 X-ray microscope (XRM) instrument (Zeiss X-Ray Microscopy, Pleasanton, CA, USA). XRM tilt series were generally collected at 120 kV and 10 W power (75 µA current) and used to create 3D reconstructions of the embedded tissue. SBEM data was collected with a 3View unit (Gatan, Inc, Pleasanton, CA, USA) installed on a Gemini field emission SEM (Carl Zeiss Microscopy, Jena, Germany). Volume was collected at 2.5 kV accelerating voltage, with a raster size of 20k × 17k and pixel dwell time of 1.0 µsec. The pixel size was 5.0 nm and section thickness was 60 nm. SBEM volumes were analyzed and annotated in 3Dmod (3dmod Version 4.11.24, Copyright (C) 1994–2021 by the Regents of the University of Colorado).</p></sec><sec id="s4-9"><title>Behavioral assay of vision</title><p>Dot avoidance behavior was carried out essentially as previously described (<xref ref-type="bibr" rid="bib22">Fague and Marsh-Armstrong, 2023</xref>). Ten informative trials were performed for each tadpole; that is, trials where the tadpoles might have initiated or changed movement, but it is unclear whether that was in response to the oncoming dot were not counted. A 50% response rate is characteristic of normal vision.</p></sec><sec id="s4-10"><title>Statistics</title><p>Statistical analyses involved the comparison of means using unpaired, two-tailed Student’s <italic>t</italic>-tests or two-way ANOVAs following Tukey’s post hoc test for multiple comparisons using GraphPad Prism software. All the bar graphs represent the means ± SEM, where values were first averaged per animal and N is the number of animals. In the stacked bar graphs (except <xref ref-type="fig" rid="fig2">Figure 2G</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>, and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H, I</xref>) showing percentage of each movement, all statistical comparisons were performed using all the axonal movements including stationary, anterograde, and retrograde, although only the statistically significant comparisons between the stationary groups (against Wt OPTN or control group) are shown. In all the velocity graphs (except <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>), all statistical comparisons were performed throughout all the transgenic lines and movements (both anterograde and retrograde movements), and only the statistically significant comparisons against the Wt OPTN or control group are shown.</p><p>All animal experiments were carried out in accordance with procedures approved by the Institutional Animal Care and Use Committee of University of California, Davis.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The study was carried out in accordance with recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal work was carried out according to approved institutional care and use committee protocols (#22908) of the University of California Davis. Surgeries and imaging were carried out under MS-222 anesthesia and all efforts were made to minimize pain or distress to the animals.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-103844-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Data has been uploaded to Dryad (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.zkh1893nt">https://doi.org/10.5061/dryad.zkh1893nt</ext-link>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Marsh-Armstrong</surname><given-names>N</given-names></name><name><surname>Jeong</surname><given-names>Y</given-names></name><name><surname>Davis</surname><given-names>CO</given-names></name><name><surname>Muscarella</surname><given-names>AM</given-names></name><name><surname>Navarro</surname><given-names>HH</given-names></name><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Moore</surname><given-names>LG</given-names></name><name><surname>Kim</surname><given-names>KY</given-names></name><name><surname>Ellisman</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Glaucoma-associated optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.zkh1893nt</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the National Eye Institute (R01EY026471 and R01EY029087) (N M-A). Correlated light, XRM, and Volume EM analysis was performed at the National Center for Microscopy and Imaging Research, with support from NIH grants U24 NS120055, 1S10OD021784 and National Science Foundation – NSF2014862-UTA20-000890 (MHE). Deposition and management of Volume EM data within the Cell Image Library was further supported by NIH grant R01 GM82949 (MHE). The authors thank Elizabeth A Mills and Ferdinand Kaya for their initial work on generating the original Isl2b- and Fabp7-promoter constructs. Image analyses were performed through the use of UC Davis Health Sciences Advanced Imaging Facility supported by the NEI UC Davis Core grant (P30-EY012576).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Amaya</surname><given-names>E</given-names></name><name><surname>Kroll</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="1999">1999</year><chapter-title>A method for generating transgenic frog embryos</chapter-title><person-group person-group-type="editor"><name><surname>Sharpe</surname><given-names>PT</given-names></name><name><surname>Mason</surname><given-names>I</given-names></name></person-group><source>In Molecular Embryology: Methods and Protocols</source><publisher-name>Humana Press</publisher-name><fpage>393</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1007/978-1-60327-483-8_31</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname><given-names>G</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The pathways of mitophagy for quality control and clearance of mitochondria</article-title><source>Cell Death and Differentiation</source><volume>20</volume><fpage>31</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1038/cdd.2012.81</pub-id><pub-id pub-id-type="pmid">22743996</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname><given-names>G</given-names></name><name><surname>Schlehe</surname><given-names>JS</given-names></name><name><surname>LaVoie</surname><given-names>MJ</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin</article-title><source>The Journal of Cell Biology</source><volume>206</volume><fpage>655</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1083/jcb.201401070</pub-id><pub-id pub-id-type="pmid">25154397</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attwell</surname><given-names>D</given-names></name><name><surname>Laughlin</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>An energy budget for signaling in the grey matter of the brain</article-title><source>Journal of Cerebral Blood Flow and Metabolism</source><volume>21</volume><fpage>1133</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1097/00004647-200110000-00001</pub-id><pub-id pub-id-type="pmid">11598490</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Audano</surname><given-names>M</given-names></name><name><surname>Pedretti</surname><given-names>S</given-names></name><name><surname>Ligorio</surname><given-names>S</given-names></name><name><surname>Gualdrini</surname><given-names>F</given-names></name><name><surname>Polletti</surname><given-names>S</given-names></name><name><surname>Russo</surname><given-names>M</given-names></name><name><surname>Ghisletti</surname><given-names>S</given-names></name><name><surname>Bean</surname><given-names>C</given-names></name><name><surname>Crestani</surname><given-names>M</given-names></name><name><surname>Caruso</surname><given-names>D</given-names></name><name><surname>De Fabiani</surname><given-names>E</given-names></name><name><surname>Mitro</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Zc3h10 regulates adipogenesis by controlling translation and F-actin/mitochondria interaction</article-title><source>The Journal of Cell Biology</source><volume>220</volume><elocation-id>e202003173</elocation-id><pub-id pub-id-type="doi">10.1083/jcb.202003173</pub-id><pub-id pub-id-type="pmid">33566069</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boecker</surname><given-names>CA</given-names></name><name><surname>Goldsmith</surname><given-names>J</given-names></name><name><surname>Dou</surname><given-names>D</given-names></name><name><surname>Cajka</surname><given-names>GG</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomes</article-title><source>Current Biology</source><volume>31</volume><fpage>2140</fpage><lpage>2154</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2021.02.061</pub-id><pub-id pub-id-type="pmid">33765413</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgoyne</surname><given-names>CF</given-names></name><name><surname>Downs</surname><given-names>JC</given-names></name><name><surname>Bellezza</surname><given-names>AJ</given-names></name><name><surname>Suh</surname><given-names>JKF</given-names></name><name><surname>Hart</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage</article-title><source>Progress in Retinal and Eye Research</source><volume>24</volume><fpage>39</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2004.06.001</pub-id><pub-id pub-id-type="pmid">15555526</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>WJ</given-names></name><name><surname>Chung</surname><given-names>HD</given-names></name><name><surname>Huang</surname><given-names>JS</given-names></name><name><surname>Huang</surname><given-names>SS</given-names></name><name><surname>Haring</surname><given-names>JH</given-names></name><name><surname>Strong</surname><given-names>R</given-names></name><name><surname>Marshall</surname><given-names>GL</given-names></name><name><surname>Joh</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Evidence for retrograde degeneration of epinephrine neurons in Alzheimer’s disease</article-title><source>Annals of Neurology</source><volume>24</volume><fpage>532</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1002/ana.410240409</pub-id><pub-id pub-id-type="pmid">3239955</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>KT</given-names></name><name><surname>Niescier</surname><given-names>RF</given-names></name><name><surname>Min</surname><given-names>KT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondrial matrix Ca2+ as an intrinsic signal regulating mitochondrial motility in axons</article-title><source>PNAS</source><volume>108</volume><fpage>15456</fpage><lpage>15461</lpage><pub-id pub-id-type="doi">10.1073/pnas.1106862108</pub-id><pub-id pub-id-type="pmid">21876166</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>R169</fpage><lpage>R176</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp326</pub-id><pub-id pub-id-type="pmid">19808793</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Du</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A new method for quantifying mitochondrial axonal transport</article-title><source>Protein &amp; Cell</source><volume>7</volume><fpage>804</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1007/s13238-016-0268-3</pub-id><pub-id pub-id-type="pmid">27225265</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>XT</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>MY</given-names></name><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Sheng</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Axonal autophagosomes recruit dynein for retrograde transport through fusion with late endosomes</article-title><source>The Journal of Cell Biology</source><volume>209</volume><fpage>377</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1083/jcb.201412046</pub-id><pub-id pub-id-type="pmid">25940348</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>XT</given-names></name><name><surname>Sheng</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Developmental regulation of microtubule-based trafficking and anchoring of axonal mitochondria in health and diseases</article-title><source>Developmental Neurobiology</source><volume>81</volume><fpage>284</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1002/dneu.22748</pub-id><pub-id pub-id-type="pmid">32302463</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chernyshova</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Yamashita</surname><given-names>SI</given-names></name><name><surname>Fukuchi</surname><given-names>T</given-names></name><name><surname>Kanki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Glaucoma-associated mutations in the optineurin gene have limited impact on parkin-dependent mitophagy</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>60</volume><fpage>3625</fpage><lpage>3635</lpage><pub-id pub-id-type="doi">10.1167/iovs.19-27184</pub-id><pub-id pub-id-type="pmid">31469402</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Controlling transgene expression to study <italic>Xenopus laevis</italic> metamorphosis</article-title><source>PNAS</source><volume>101</volume><fpage>4839</fpage><lpage>4842</lpage><pub-id pub-id-type="doi">10.1073/pnas.0401011101</pub-id><pub-id pub-id-type="pmid">15047886</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>CO</given-names></name><name><surname>Kim</surname><given-names>K-Y</given-names></name><name><surname>Bushong</surname><given-names>EA</given-names></name><name><surname>Mills</surname><given-names>EA</given-names></name><name><surname>Boassa</surname><given-names>D</given-names></name><name><surname>Shih</surname><given-names>T</given-names></name><name><surname>Kinebuchi</surname><given-names>M</given-names></name><name><surname>Phan</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Bihlmeyer</surname><given-names>NA</given-names></name><name><surname>Nguyen</surname><given-names>JV</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Ellisman</surname><given-names>MH</given-names></name><name><surname>Marsh-Armstrong</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Transcellular degradation of axonal mitochondria</article-title><source>PNAS</source><volume>111</volume><fpage>9633</fpage><lpage>9638</lpage><pub-id pub-id-type="doi">10.1073/pnas.1404651111</pub-id><pub-id pub-id-type="pmid">24979790</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vos</surname><given-names>KJ</given-names></name><name><surname>Sable</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>KE</given-names></name><name><surname>Sheetz</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Expression of phosphatidylinositol (4,5) bisphosphate-specific pleckstrin homology domains alters direction but not the level of axonal transport of mitochondria</article-title><source>Molecular Biology of the Cell</source><volume>14</volume><fpage>3636</fpage><lpage>3649</lpage><pub-id pub-id-type="doi">10.1091/mbc.e02-10-0638</pub-id><pub-id pub-id-type="pmid">12972553</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deerinck</surname><given-names>T</given-names></name><name><surname>Bushong</surname><given-names>E</given-names></name><name><surname>Lev-Ram</surname><given-names>V</given-names></name><name><surname>Shu</surname><given-names>X</given-names></name><name><surname>Tsien</surname><given-names>R</given-names></name><name><surname>Ellisman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Enhancing serial block-face scanning electron microscopy to enable high resolution 3-D nanohistology of cells and tissues</article-title><source>Microscopy and Microanalysis</source><volume>16</volume><fpage>1138</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1017/S1431927610055170</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>WX</given-names></name><name><surname>Yin</surname><given-names>XM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitophagy: mechanisms, pathophysiological roles, and analysis</article-title><source>Biological Chemistry</source><volume>393</volume><fpage>547</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1515/hsz-2012-0119</pub-id><pub-id pub-id-type="pmid">22944659</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>RH</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Pratt</surname><given-names>KG</given-names></name><name><surname>Cao</surname><given-names>V</given-names></name><name><surname>Song</surname><given-names>YK</given-names></name><name><surname>Nurmikko</surname><given-names>A</given-names></name><name><surname>Aizenman</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Visual avoidance in Xenopus tadpoles is correlated with the maturation of visual responses in the optic tectum</article-title><source>Journal of Neurophysiology</source><volume>101</volume><fpage>803</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1152/jn.90848.2008</pub-id><pub-id pub-id-type="pmid">19073807</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>CS</given-names></name><name><surname>Holzbaur</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons</article-title><source>eLife</source><volume>9</volume><elocation-id>e50260</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.50260</pub-id><pub-id pub-id-type="pmid">31934852</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fague</surname><given-names>L</given-names></name><name><surname>Marsh-Armstrong</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Dual leucine zipper kinase is necessary for retinal ganglion cell axonal regeneration in <italic>Xenopus laevis</italic></article-title><source>PNAS Nexus</source><volume>2</volume><elocation-id>gad109</elocation-id><pub-id pub-id-type="doi">10.1093/pnasnexus/pgad109</pub-id><pub-id pub-id-type="pmid">37152673</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fellows</surname><given-names>AD</given-names></name><name><surname>Rhymes</surname><given-names>ER</given-names></name><name><surname>Gibbs</surname><given-names>KL</given-names></name><name><surname>Greensmith</surname><given-names>L</given-names></name><name><surname>Schiavo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>IGF1R regulates retrograde axonal transport of signalling endosomes in motor neurons</article-title><source>EMBO Reports</source><volume>21</volume><elocation-id>e49129</elocation-id><pub-id pub-id-type="doi">10.15252/embr.201949129</pub-id><pub-id pub-id-type="pmid">32030864</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferree</surname><given-names>AW</given-names></name><name><surname>Trudeau</surname><given-names>K</given-names></name><name><surname>Zik</surname><given-names>E</given-names></name><name><surname>Benador</surname><given-names>IY</given-names></name><name><surname>Twig</surname><given-names>G</given-names></name><name><surname>Gottlieb</surname><given-names>RA</given-names></name><name><surname>Shirihai</surname><given-names>OS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MitoTimer probe reveals the impact of autophagy, fusion, and motility on subcellular distribution of young and old mitochondrial protein and on relative mitochondrial protein age</article-title><source>Autophagy</source><volume>9</volume><fpage>1887</fpage><lpage>1896</lpage><pub-id pub-id-type="doi">10.4161/auto.26503</pub-id><pub-id pub-id-type="pmid">24149000</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>M-M</given-names></name><name><surname>Nirschl</surname><given-names>JJ</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>LC3 binding to the scaffolding protein JIP1 regulates processive dynein-driven transport of autophagosomes</article-title><source>Developmental Cell</source><volume>29</volume><fpage>577</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.04.015</pub-id><pub-id pub-id-type="pmid">24914561</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>C</given-names></name><name><surname>VanderWall</surname><given-names>KB</given-names></name><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Lavekar</surname><given-names>SS</given-names></name><name><surname>Huang</surname><given-names>KC</given-names></name><name><surname>Fligor</surname><given-names>CM</given-names></name><name><surname>Harkin</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Cummins</surname><given-names>TR</given-names></name><name><surname>Meyer</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Astrocytes modulate neurodegenerative phenotypes associated with glaucoma in OPTN(E50K) human stem cell-derived retinal ganglion cells</article-title><source>Stem Cell Reports</source><volume>17</volume><fpage>1636</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2022.05.006</pub-id><pub-id pub-id-type="pmid">35714595</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harbauer</surname><given-names>AB</given-names></name><name><surname>Hees</surname><given-names>JT</given-names></name><name><surname>Wanderoy</surname><given-names>S</given-names></name><name><surname>Segura</surname><given-names>I</given-names></name><name><surname>Gibbs</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Ordonez</surname><given-names>M</given-names></name><name><surname>Cai</surname><given-names>Z</given-names></name><name><surname>Cartoni</surname><given-names>R</given-names></name><name><surname>Ashrafi</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Perocchi</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Neuronal mitochondria transport Pink1 mRNA via synaptojanin 2 to support local mitophagy</article-title><source>Neuron</source><volume>110</volume><fpage>1516</fpage><lpage>1531</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2022.01.035</pub-id><pub-id pub-id-type="pmid">35216662</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>JM</given-names></name><name><surname>Ordureau</surname><given-names>A</given-names></name><name><surname>Paulo</surname><given-names>JA</given-names></name><name><surname>Rinehart</surname><given-names>J</given-names></name><name><surname>Harper</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy</article-title><source>Molecular Cell</source><volume>60</volume><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.08.016</pub-id><pub-id pub-id-type="pmid">26365381</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>G</given-names></name><name><surname>Thornton</surname><given-names>C</given-names></name><name><surname>Stotland</surname><given-names>A</given-names></name><name><surname>Lui</surname><given-names>D</given-names></name><name><surname>Sin</surname><given-names>J</given-names></name><name><surname>Ramil</surname><given-names>J</given-names></name><name><surname>Magee</surname><given-names>N</given-names></name><name><surname>Andres</surname><given-names>A</given-names></name><name><surname>Quarato</surname><given-names>G</given-names></name><name><surname>Carreira</surname><given-names>RS</given-names></name><name><surname>Sayen</surname><given-names>MR</given-names></name><name><surname>Wolkowicz</surname><given-names>R</given-names></name><name><surname>Gottlieb</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MitoTimer: a novel tool for monitoring mitochondrial turnover</article-title><source>Autophagy</source><volume>9</volume><fpage>1852</fpage><lpage>1861</lpage><pub-id pub-id-type="doi">10.4161/auto.26501</pub-id><pub-id pub-id-type="pmid">24128932</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollenbeck</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Products of endocytosis and autophagy are retrieved from axons by regulated retrograde organelle transport</article-title><source>The Journal of Cell Biology</source><volume>121</volume><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1083/jcb.121.2.305</pub-id><pub-id pub-id-type="pmid">7682217</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>CH</given-names></name><name><surname>Shaltouki</surname><given-names>A</given-names></name><name><surname>Gonzalez</surname><given-names>AE</given-names></name><name><surname>Bettencourt da Cruz</surname><given-names>A</given-names></name><name><surname>Burbulla</surname><given-names>LF</given-names></name><name><surname>St Lawrence</surname><given-names>E</given-names></name><name><surname>Schüle</surname><given-names>B</given-names></name><name><surname>Krainc</surname><given-names>D</given-names></name><name><surname>Palmer</surname><given-names>TD</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Functional impairment in miro degradation and mitophagy is a shared feature in familial and sporadic parkinson’s disease</article-title><source>Cell Stem Cell</source><volume>19</volume><fpage>709</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.08.002</pub-id><pub-id pub-id-type="pmid">27618216</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structure of Myosin VI/Tom1 complex reveals a cargo recognition mode of Myosin VI for tethering</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>3459</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-11481-6</pub-id><pub-id pub-id-type="pmid">31371777</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutto</surname><given-names>RA</given-names></name><name><surname>Rutter</surname><given-names>KM</given-names></name><name><surname>Giarmarco</surname><given-names>MM</given-names></name><name><surname>Parker</surname><given-names>ED</given-names></name><name><surname>Chambers</surname><given-names>ZS</given-names></name><name><surname>Brockerhoff</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cone photoreceptors transfer damaged mitochondria to Müller glia</article-title><source>Cell Reports</source><volume>42</volume><elocation-id>112115</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112115</pub-id><pub-id pub-id-type="pmid">36795565</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiménez-Mateos</surname><given-names>EM</given-names></name><name><surname>González-Billault</surname><given-names>C</given-names></name><name><surname>Dawson</surname><given-names>HN</given-names></name><name><surname>Vitek</surname><given-names>MP</given-names></name><name><surname>Avila</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Role of MAP1B in axonal retrograde transport of mitochondria</article-title><source>The Biochemical Journal</source><volume>397</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1042/BJ20060205</pub-id><pub-id pub-id-type="pmid">16536727</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaltimbacher</surname><given-names>V</given-names></name><name><surname>Bonnet</surname><given-names>C</given-names></name><name><surname>Lecoeuvre</surname><given-names>G</given-names></name><name><surname>Forster</surname><given-names>V</given-names></name><name><surname>Sahel</surname><given-names>JA</given-names></name><name><surname>Corral-Debrinski</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>mRNA localization to the mitochondrial surface allows the efficient translocation inside the organelle of a nuclear recoded ATP6 protein</article-title><source>RNA</source><volume>12</volume><fpage>1408</fpage><lpage>1417</lpage><pub-id pub-id-type="doi">10.1261/rna.18206</pub-id><pub-id pub-id-type="pmid">16751614</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>JS</given-names></name><name><surname>Tian</surname><given-names>JH</given-names></name><name><surname>Pan</surname><given-names>PY</given-names></name><name><surname>Zald</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>Sheng</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation</article-title><source>Cell</source><volume>132</volume><fpage>137</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.11.024</pub-id><pub-id pub-id-type="pmid">18191227</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitada</surname><given-names>T</given-names></name><name><surname>Asakawa</surname><given-names>S</given-names></name><name><surname>Hattori</surname><given-names>N</given-names></name><name><surname>Matsumine</surname><given-names>H</given-names></name><name><surname>Yamamura</surname><given-names>Y</given-names></name><name><surname>Minoshima</surname><given-names>S</given-names></name><name><surname>Yokochi</surname><given-names>M</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism</article-title><source>Nature</source><volume>392</volume><fpage>605</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1038/33416</pub-id><pub-id pub-id-type="pmid">9560156</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korac</surname><given-names>J</given-names></name><name><surname>Schaeffer</surname><given-names>V</given-names></name><name><surname>Kovacevic</surname><given-names>I</given-names></name><name><surname>Clement</surname><given-names>AM</given-names></name><name><surname>Jungblut</surname><given-names>B</given-names></name><name><surname>Behl</surname><given-names>C</given-names></name><name><surname>Terzic</surname><given-names>J</given-names></name><name><surname>Dikic</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>580</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1242/jcs.114926</pub-id><pub-id pub-id-type="pmid">23178947</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroll</surname><given-names>KL</given-names></name><name><surname>Amaya</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation</article-title><source>Development</source><volume>122</volume><fpage>3173</fpage><lpage>3183</lpage><pub-id pub-id-type="doi">10.1242/dev.122.10.3173</pub-id><pub-id pub-id-type="pmid">8898230</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuijpers</surname><given-names>M</given-names></name><name><surname>Kochlamazashvili</surname><given-names>G</given-names></name><name><surname>Stumpf</surname><given-names>A</given-names></name><name><surname>Puchkov</surname><given-names>D</given-names></name><name><surname>Swaminathan</surname><given-names>A</given-names></name><name><surname>Lucht</surname><given-names>MT</given-names></name><name><surname>Krause</surname><given-names>E</given-names></name><name><surname>Maritzen</surname><given-names>T</given-names></name><name><surname>Schmitz</surname><given-names>D</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neuronal autophagy regulates presynaptic neurotransmission by controlling the axonal endoplasmic reticulum</article-title><source>Neuron</source><volume>109</volume><fpage>299</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.10.005</pub-id><pub-id pub-id-type="pmid">33157003</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampinen</surname><given-names>R</given-names></name><name><surname>Belaya</surname><given-names>I</given-names></name><name><surname>Saveleva</surname><given-names>L</given-names></name><name><surname>Liddell</surname><given-names>JR</given-names></name><name><surname>Rait</surname><given-names>D</given-names></name><name><surname>Huuskonen</surname><given-names>MT</given-names></name><name><surname>Giniatullina</surname><given-names>R</given-names></name><name><surname>Sorvari</surname><given-names>A</given-names></name><name><surname>Soppela</surname><given-names>L</given-names></name><name><surname>Mikhailov</surname><given-names>N</given-names></name><name><surname>Boccuni</surname><given-names>I</given-names></name><name><surname>Giniatullin</surname><given-names>R</given-names></name><name><surname>Cruz-Haces</surname><given-names>M</given-names></name><name><surname>Konovalova</surname><given-names>J</given-names></name><name><surname>Koskuvi</surname><given-names>M</given-names></name><name><surname>Domanskyi</surname><given-names>A</given-names></name><name><surname>Hämäläinen</surname><given-names>RH</given-names></name><name><surname>Goldsteins</surname><given-names>G</given-names></name><name><surname>Koistinaho</surname><given-names>J</given-names></name><name><surname>Malm</surname><given-names>T</given-names></name><name><surname>Chew</surname><given-names>S</given-names></name><name><surname>Rilla</surname><given-names>K</given-names></name><name><surname>White</surname><given-names>AR</given-names></name><name><surname>Marsh-Armstrong</surname><given-names>N</given-names></name><name><surname>Kanninen</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Neuron-astrocyte transmitophagy is altered in Alzheimer’s disease</article-title><source>Neurobiology of Disease</source><volume>170</volume><elocation-id>105753</elocation-id><pub-id pub-id-type="doi">10.1016/j.nbd.2022.105753</pub-id><pub-id pub-id-type="pmid">35569719</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarou</surname><given-names>M</given-names></name><name><surname>Sliter</surname><given-names>DA</given-names></name><name><surname>Kane</surname><given-names>LA</given-names></name><name><surname>Sarraf</surname><given-names>SA</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Burman</surname><given-names>JL</given-names></name><name><surname>Sideris</surname><given-names>DP</given-names></name><name><surname>Fogel</surname><given-names>AI</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy</article-title><source>Nature</source><volume>524</volume><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1038/nature14893</pub-id><pub-id pub-id-type="pmid">26266977</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>HC</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Borzan</surname><given-names>J</given-names></name><name><surname>Mankowski</surname><given-names>JL</given-names></name><name><surname>Höke</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy</article-title><source>Annals of Neurology</source><volume>69</volume><fpage>100</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1002/ana.22150</pub-id><pub-id pub-id-type="pmid">21280080</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation</article-title><source>Autophagy</source><volume>14</volume><fpage>66</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1080/15548627.2017.1391970</pub-id><pub-id pub-id-type="pmid">29394115</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ligon</surname><given-names>LA</given-names></name><name><surname>Steward</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Movement of mitochondria in the axons and dendrites of cultured hippocampal neurons</article-title><source>The Journal of Comparative Neurology</source><volume>427</volume><fpage>340</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1002/1096-9861(20001120)427:3&lt;340::aid-cne2&gt;3.0.co;2-y</pub-id><pub-id pub-id-type="pmid">11054697</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Sawada</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Silverio</surname><given-names>G</given-names></name><name><surname>Alapatt</surname><given-names>P</given-names></name><name><surname>Millan</surname><given-names>I</given-names></name><name><surname>Shen</surname><given-names>A</given-names></name><name><surname>Saxton</surname><given-names>W</given-names></name><name><surname>Kanao</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>R</given-names></name><name><surname>Hattori</surname><given-names>N</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Parkinson’s disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria</article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1002537</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002537</pub-id><pub-id pub-id-type="pmid">22396657</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Hong</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Yue</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>You</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Weng</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>ALS-associated E478G mutation in human OPTN (Optineurin) promotes inflammation and induces neuronal cell death</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>2647</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02647</pub-id><pub-id pub-id-type="pmid">30519240</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovas</surname><given-names>JR</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The meaning of mitochondrial movement to a neuron’s life</article-title><source>Biochimica et Biophysica Acta</source><volume>1833</volume><fpage>184</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2012.04.007</pub-id><pub-id pub-id-type="pmid">22548961</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neuronal mitophagy: long-distance delivery or eating locally?</article-title><source>Current Biology</source><volume>24</volume><fpage>R1006</fpage><lpage>R1008</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2014.09.037</pub-id><pub-id pub-id-type="pmid">25442848</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacAskill</surname><given-names>AF</given-names></name><name><surname>Kittler</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Control of mitochondrial transport and localization in neurons</article-title><source>Trends in Cell Biology</source><volume>20</volume><fpage>102</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2009.11.002</pub-id><pub-id pub-id-type="pmid">20006503</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname><given-names>S</given-names></name><name><surname>Wallace</surname><given-names>KE</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons</article-title><source>The Journal of Cell Biology</source><volume>196</volume><fpage>407</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1083/jcb.201106120</pub-id><pub-id pub-id-type="pmid">22331844</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname><given-names>S</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Autophagosome biogenesis in primary neurons follows an ordered and spatially regulated pathway</article-title><source>Developmental Cell</source><volume>30</volume><fpage>71</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.06.001</pub-id><pub-id pub-id-type="pmid">25026034</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melentijevic</surname><given-names>I</given-names></name><name><surname>Toth</surname><given-names>ML</given-names></name><name><surname>Arnold</surname><given-names>ML</given-names></name><name><surname>Guasp</surname><given-names>RJ</given-names></name><name><surname>Harinath</surname><given-names>G</given-names></name><name><surname>Nguyen</surname><given-names>KC</given-names></name><name><surname>Taub</surname><given-names>D</given-names></name><name><surname>Parker</surname><given-names>JA</given-names></name><name><surname>Neri</surname><given-names>C</given-names></name><name><surname>Gabel</surname><given-names>CV</given-names></name><name><surname>Hall</surname><given-names>DH</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title><italic>C. elegans</italic> neurons jettison protein aggregates and mitochondria under neurotoxic stress</article-title><source>Nature</source><volume>542</volume><fpage>367</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1038/nature21362</pub-id><pub-id pub-id-type="pmid">28178240</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Xue</surname><given-names>F</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Meng</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transgenic mice with overexpression of mutated human optineurin(E50K) in the retina</article-title><source>Molecular Biology Reports</source><volume>39</volume><fpage>1119</fpage><lpage>1124</lpage><pub-id pub-id-type="doi">10.1007/s11033-011-0840-0</pub-id><pub-id pub-id-type="pmid">21681420</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>KE</given-names></name><name><surname>Sheetz</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Axonal mitochondrial transport and potential are correlated</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>2791</fpage><lpage>2804</lpage><pub-id pub-id-type="doi">10.1242/jcs.01130</pub-id><pub-id pub-id-type="pmid">15150321</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>EA</given-names></name><name><surname>Davis</surname><given-names>CO</given-names></name><name><surname>Bushong</surname><given-names>EA</given-names></name><name><surname>Boassa</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>K-Y</given-names></name><name><surname>Ellisman</surname><given-names>MH</given-names></name><name><surname>Marsh-Armstrong</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Astrocytes phagocytose focal dystrophies from shortening myelin segments in the optic nerve of <italic>Xenopus laevis</italic> at metamorphosis</article-title><source>PNAS</source><volume>112</volume><fpage>10509</fpage><lpage>10514</lpage><pub-id pub-id-type="doi">10.1073/pnas.1506486112</pub-id><pub-id pub-id-type="pmid">26240339</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minegishi</surname><given-names>Y</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Iejima</surname><given-names>D</given-names></name><name><surname>Kawase</surname><given-names>K</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Significance of optineurin mutations in glaucoma and other diseases</article-title><source>Progress in Retinal and Eye Research</source><volume>55</volume><fpage>149</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2016.08.002</pub-id><pub-id pub-id-type="pmid">27693724</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mironov</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>ADP regulates movements of mitochondria in neurons</article-title><source>Biophysical Journal</source><volume>92</volume><fpage>2944</fpage><lpage>2952</lpage><pub-id pub-id-type="doi">10.1529/biophysj.106.092981</pub-id><pub-id pub-id-type="pmid">17277190</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misgeld</surname><given-names>T</given-names></name><name><surname>Kerschensteiner</surname><given-names>M</given-names></name><name><surname>Bareyre</surname><given-names>FM</given-names></name><name><surname>Burgess</surname><given-names>RW</given-names></name><name><surname>Lichtman</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Imaging axonal transport of mitochondria in vivo</article-title><source>Nature Methods</source><volume>4</volume><fpage>559</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1038/nmeth1055</pub-id><pub-id pub-id-type="pmid">17558414</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Komatsu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Autophagy: renovation of cells and tissues</article-title><source>Cell</source><volume>147</volume><fpage>728</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.026</pub-id><pub-id pub-id-type="pmid">22078875</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>AS</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy</article-title><source>PNAS</source><volume>113</volume><fpage>E3349</fpage><lpage>E3358</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523810113</pub-id><pub-id pub-id-type="pmid">27247382</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>I</given-names></name><name><surname>Sanchez</surname><given-names>A</given-names></name><name><surname>Puertas-Avendaño</surname><given-names>R</given-names></name><name><surname>Rodriguez-Sabate</surname><given-names>C</given-names></name><name><surname>Perez-Barreto</surname><given-names>A</given-names></name><name><surname>Rodriguez</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuroglial transmitophagy and Parkinson’s disease</article-title><source>Glia</source><volume>68</volume><fpage>2277</fpage><lpage>2299</lpage><pub-id pub-id-type="doi">10.1002/glia.23839</pub-id><pub-id pub-id-type="pmid">32415886</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>RL</given-names></name><name><surname>Hollenbeck</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth</article-title><source>Journal of Cell Science</source><volume>104 ( Pt 3)</volume><fpage>917</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1242/jcs.104.3.917</pub-id><pub-id pub-id-type="pmid">8314882</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherji</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>MS</given-names></name><name><surname>Zheng</surname><given-names>GXY</given-names></name><name><surname>Tsang</surname><given-names>JS</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MicroRNAs can generate thresholds in target gene expression</article-title><source>Nature Genetics</source><volume>43</volume><fpage>854</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1038/ng.905</pub-id><pub-id pub-id-type="pmid">21857679</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nafstad</surname><given-names>PHJ</given-names></name><name><surname>Blackstad</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="1966">1966</year><article-title>Distribution of mitochondria in pyramidal cells and boutons in hippocampal cortex</article-title><source>Zeitschrift Für Zellforschung Und Mikroskopische Anatomie</source><volume>73</volume><fpage>234</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1007/BF00334866</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narendra</surname><given-names>D</given-names></name><name><surname>Tanaka</surname><given-names>A</given-names></name><name><surname>Suen</surname><given-names>DF</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Parkin is recruited selectively to impaired mitochondria and promotes their autophagy</article-title><source>The Journal of Cell Biology</source><volume>183</volume><fpage>795</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1083/jcb.200809125</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>JV</given-names></name><name><surname>Soto</surname><given-names>I</given-names></name><name><surname>Kim</surname><given-names>K-Y</given-names></name><name><surname>Bushong</surname><given-names>EA</given-names></name><name><surname>Oglesby</surname><given-names>E</given-names></name><name><surname>Valiente-Soriano</surname><given-names>FJ</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Davis</surname><given-names>CO</given-names></name><name><surname>Bedont</surname><given-names>JL</given-names></name><name><surname>Son</surname><given-names>JL</given-names></name><name><surname>Wei</surname><given-names>JO</given-names></name><name><surname>Buchman</surname><given-names>VL</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name><name><surname>Vidal-Sanz</surname><given-names>M</given-names></name><name><surname>Ellisman</surname><given-names>MH</given-names></name><name><surname>Marsh-Armstrong</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma</article-title><source>PNAS</source><volume>108</volume><fpage>1176</fpage><lpage>1181</lpage><pub-id pub-id-type="doi">10.1073/pnas.1013965108</pub-id><pub-id pub-id-type="pmid">21199938</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolás-Ávila</surname><given-names>JA</given-names></name><name><surname>Lechuga-Vieco</surname><given-names>AV</given-names></name><name><surname>Esteban-Martínez</surname><given-names>L</given-names></name><name><surname>Sánchez-Díaz</surname><given-names>M</given-names></name><name><surname>Díaz-García</surname><given-names>E</given-names></name><name><surname>Santiago</surname><given-names>DJ</given-names></name><name><surname>Rubio-Ponce</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>JL</given-names></name><name><surname>Balachander</surname><given-names>A</given-names></name><name><surname>Quintana</surname><given-names>JA</given-names></name><name><surname>Martínez-de-Mena</surname><given-names>R</given-names></name><name><surname>Castejón-Vega</surname><given-names>B</given-names></name><name><surname>Pun-García</surname><given-names>A</given-names></name><name><surname>Través</surname><given-names>PG</given-names></name><name><surname>Bonzón-Kulichenko</surname><given-names>E</given-names></name><name><surname>García-Marqués</surname><given-names>F</given-names></name><name><surname>Cussó</surname><given-names>L</given-names></name><name><surname>A-González</surname><given-names>N</given-names></name><name><surname>González-Guerra</surname><given-names>A</given-names></name><name><surname>Roche-Molina</surname><given-names>M</given-names></name><name><surname>Martin-Salamanca</surname><given-names>S</given-names></name><name><surname>Crainiciuc</surname><given-names>G</given-names></name><name><surname>Guzmán</surname><given-names>G</given-names></name><name><surname>Larrazabal</surname><given-names>J</given-names></name><name><surname>Herrero-Galán</surname><given-names>E</given-names></name><name><surname>Alegre-Cebollada</surname><given-names>J</given-names></name><name><surname>Lemke</surname><given-names>G</given-names></name><name><surname>Rothlin</surname><given-names>CV</given-names></name><name><surname>Jimenez-Borreguero</surname><given-names>LJ</given-names></name><name><surname>Reyes</surname><given-names>G</given-names></name><name><surname>Castrillo</surname><given-names>A</given-names></name><name><surname>Desco</surname><given-names>M</given-names></name><name><surname>Muñoz-Cánoves</surname><given-names>P</given-names></name><name><surname>Ibáñez</surname><given-names>B</given-names></name><name><surname>Torres</surname><given-names>M</given-names></name><name><surname>Ng</surname><given-names>LG</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Bueno</surname><given-names>H</given-names></name><name><surname>Vázquez</surname><given-names>J</given-names></name><name><surname>Cordero</surname><given-names>MD</given-names></name><name><surname>Bernal</surname><given-names>JA</given-names></name><name><surname>Enríquez</surname><given-names>JA</given-names></name><name><surname>Hidalgo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A network of macrophages supports mitochondrial homeostasis in the heart</article-title><source>Cell</source><volume>183</volume><fpage>94</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.08.031</pub-id><pub-id pub-id-type="pmid">32937105</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niescier</surname><given-names>RF</given-names></name><name><surname>Kwak</surname><given-names>SK</given-names></name><name><surname>Joo</surname><given-names>SH</given-names></name><name><surname>Chang</surname><given-names>KT</given-names></name><name><surname>Min</surname><given-names>KT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dynamics of mitochondrial transport in axons</article-title><source>Frontiers in Cellular Neuroscience</source><volume>10</volume><elocation-id>123</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2016.00123</pub-id><pub-id pub-id-type="pmid">27242435</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nieuwkoop</surname><given-names>PD</given-names></name><name><surname>Faber</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1994">1994</year><source>Normal Table of Xenopus laevis</source><publisher-name>Garland Publishing Inc</publisher-name><pub-id pub-id-type="doi">10.1201/9781003064565</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owada</surname><given-names>Y</given-names></name><name><surname>Yoshimoto</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Spatio-temporally differential expression of genes for three members of fatty acid binding proteins in developing and mature rat brains</article-title><source>Journal of Chemical Neuroanatomy</source><volume>12</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/s0891-0618(96)00192-5</pub-id><pub-id pub-id-type="pmid">9115666</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padman</surname><given-names>BS</given-names></name><name><surname>Nguyen</surname><given-names>TN</given-names></name><name><surname>Uoselis</surname><given-names>L</given-names></name><name><surname>Skulsuppaisarn</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>LK</given-names></name><name><surname>Lazarou</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>LC3/GABARAPs drive ubiquitin-independent recruitment of Optineurin and NDP52 to amplify mitophagy</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>408</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-08335-6</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilling</surname><given-names>AD</given-names></name><name><surname>Horiuchi</surname><given-names>D</given-names></name><name><surname>Lively</surname><given-names>CM</given-names></name><name><surname>Saxton</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in <italic>Drosophila</italic> motor axons</article-title><source>Molecular Biology of the Cell</source><volume>17</volume><fpage>2057</fpage><lpage>2068</lpage><pub-id pub-id-type="doi">10.1091/mbc.e05-06-0526</pub-id><pub-id pub-id-type="pmid">16467387</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pittman</surname><given-names>AJ</given-names></name><name><surname>Law</surname><given-names>MY</given-names></name><name><surname>Chien</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Pathfinding in a large vertebrate axon tract: isotypic interactions guide retinotectal axons at multiple choice points</article-title><source>Development</source><volume>135</volume><fpage>2865</fpage><lpage>2871</lpage><pub-id pub-id-type="doi">10.1242/dev.025049</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezaie</surname><given-names>T</given-names></name><name><surname>Child</surname><given-names>A</given-names></name><name><surname>Hitchings</surname><given-names>R</given-names></name><name><surname>Brice</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>L</given-names></name><name><surname>Coca-Prados</surname><given-names>M</given-names></name><name><surname>Héon</surname><given-names>E</given-names></name><name><surname>Krupin</surname><given-names>T</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name><name><surname>Kreutzer</surname><given-names>D</given-names></name><name><surname>Crick</surname><given-names>RP</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Adult-onset primary open-angle glaucoma caused by mutations in optineurin</article-title><source>Science</source><volume>295</volume><fpage>1077</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1126/science.1066901</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogov</surname><given-names>V</given-names></name><name><surname>Dötsch</surname><given-names>V</given-names></name><name><surname>Johansen</surname><given-names>T</given-names></name><name><surname>Kirkin</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy</article-title><source>Molecular Cell</source><volume>53</volume><fpage>167</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.12.014</pub-id><pub-id pub-id-type="pmid">24462201</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rugarli</surname><given-names>EI</given-names></name><name><surname>Langer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitochondrial quality control: a matter of life and death for neurons: Mitochondrial quality control and neurodegeneration</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>1336</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.38</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxton</surname><given-names>WM</given-names></name><name><surname>Hollenbeck</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The axonal transport of mitochondria</article-title><source>Journal of Cell Science</source><volume>125</volume><fpage>2095</fpage><lpage>2104</lpage><pub-id pub-id-type="doi">10.1242/jcs.053850</pub-id><pub-id pub-id-type="pmid">22619228</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schon</surname><given-names>EA</given-names></name><name><surname>Przedborski</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondria: the next (neurode)generation</article-title><source>Neuron</source><volume>70</volume><fpage>1033</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.06.003</pub-id><pub-id pub-id-type="pmid">21689593</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharifi</surname><given-names>K</given-names></name><name><surname>Morihiro</surname><given-names>Y</given-names></name><name><surname>Maekawa</surname><given-names>M</given-names></name><name><surname>Yasumoto</surname><given-names>Y</given-names></name><name><surname>Hoshi</surname><given-names>H</given-names></name><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Sawada</surname><given-names>T</given-names></name><name><surname>Tokuda</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Owada</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation</article-title><source>Histochemistry and Cell Biology</source><volume>136</volume><fpage>501</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1007/s00418-011-0865-4</pub-id><pub-id pub-id-type="pmid">21938553</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>MS</given-names></name><name><surname>Takihara</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>KY</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name><name><surname>Yue</surname><given-names>BYJT</given-names></name><name><surname>Inatani</surname><given-names>M</given-names></name><name><surname>Weinreb</surname><given-names>RN</given-names></name><name><surname>Perkins</surname><given-names>GA</given-names></name><name><surname>Ju</surname><given-names>WK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial pathogenic mechanism and degradation in optineurin E50K mutation-mediated retinal ganglion cell degeneration</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>33830</elocation-id><pub-id pub-id-type="doi">10.1038/srep33830</pub-id><pub-id pub-id-type="pmid">27654856</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigal</surname><given-names>IA</given-names></name><name><surname>Flanagan</surname><given-names>JG</given-names></name><name><surname>Ethier</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Factors influencing optic nerve head biomechanics</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>46</volume><fpage>4189</fpage><lpage>4199</lpage><pub-id pub-id-type="doi">10.1167/iovs.05-0541</pub-id><pub-id pub-id-type="pmid">16249498</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirohi</surname><given-names>K</given-names></name><name><surname>Kumari</surname><given-names>A</given-names></name><name><surname>Radha</surname><given-names>V</given-names></name><name><surname>Swarup</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A glaucoma-associated variant of optineurin, M98K, activates Tbk1 to enhance autophagosome formation and retinal cell death dependent on Ser177 phosphorylation of optineurin</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0138289</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0138289</pub-id><pub-id pub-id-type="pmid">26376340</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>GJ</given-names></name><name><surname>Jeon</surname><given-names>H</given-names></name><name><surname>Seo</surname><given-names>M</given-names></name><name><surname>Jo</surname><given-names>M</given-names></name><name><surname>Suk</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interaction between optineurin and Rab1a regulates autophagosome formation in neuroblastoma cells</article-title><source>Journal of Neuroscience Research</source><volume>96</volume><fpage>407</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1002/jnr.24143</pub-id><pub-id pub-id-type="pmid">28843006</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soukup</surname><given-names>S-F</given-names></name><name><surname>Kuenen</surname><given-names>S</given-names></name><name><surname>Vanhauwaert</surname><given-names>R</given-names></name><name><surname>Manetsberger</surname><given-names>J</given-names></name><name><surname>Hernández-Díaz</surname><given-names>S</given-names></name><name><surname>Swerts</surname><given-names>J</given-names></name><name><surname>Schoovaerts</surname><given-names>N</given-names></name><name><surname>Vilain</surname><given-names>S</given-names></name><name><surname>Gounko</surname><given-names>NV</given-names></name><name><surname>Vints</surname><given-names>K</given-names></name><name><surname>Geens</surname><given-names>A</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name><name><surname>Verstreken</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A LRRK2-dependent endophilinA Phosphoswitch is critical for macroautophagy at presynaptic terminals</article-title><source>Neuron</source><volume>92</volume><fpage>829</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.09.037</pub-id><pub-id pub-id-type="pmid">27720484</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavoe</surname><given-names>AKH</given-names></name><name><surname>Kargbo-Hill</surname><given-names>SE</given-names></name><name><surname>Hall</surname><given-names>DH</given-names></name><name><surname>Colón-Ramos</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>KIF1A/UNC-104 transports ATG-9 to regulate neurodevelopment and autophagy at synapses</article-title><source>Developmental Cell</source><volume>38</volume><fpage>171</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2016.06.012</pub-id><pub-id pub-id-type="pmid">27396362</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavoe</surname><given-names>AK</given-names></name><name><surname>Gopal</surname><given-names>PP</given-names></name><name><surname>Gubas</surname><given-names>A</given-names></name><name><surname>Tooze</surname><given-names>SA</given-names></name><name><surname>Holzbaur</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Expression of WIPI2B counteracts age-related decline in autophagosome biogenesis in neurons</article-title><source>eLife</source><volume>8</volume><elocation-id>e44219</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.44219</pub-id><pub-id pub-id-type="pmid">31309927</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolz</surname><given-names>A</given-names></name><name><surname>Ernst</surname><given-names>A</given-names></name><name><surname>Dikic</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cargo recognition and trafficking in selective autophagy</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1038/ncb2979</pub-id><pub-id pub-id-type="pmid">24875736</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subach</surname><given-names>OM</given-names></name><name><surname>Cranfill</surname><given-names>PJ</given-names></name><name><surname>Davidson</surname><given-names>MW</given-names></name><name><surname>Verkhusha</surname><given-names>VV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>An enhanced monomeric blue fluorescent protein with the high chemical stability of the chromophore</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e28674</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0028674</pub-id><pub-id pub-id-type="pmid">22174863</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>BK</given-names></name><name><surname>Lee</surname><given-names>SA</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Suh</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Woo</surname><given-names>Y</given-names></name><name><surname>Nhung</surname><given-names>TTM</given-names></name><name><surname>Lee</surname><given-names>SB</given-names></name><name><surname>Mun</surname><given-names>DJ</given-names></name><name><surname>Goo</surname><given-names>BS</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Schizophrenia-associated dysbindin modulates axonal mitochondrial movement in cooperation with p150<sup>glued</sup></article-title><source>Molecular Brain</source><volume>14</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.1186/s13041-020-00720-3</pub-id><pub-id pub-id-type="pmid">33461576</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammineni</surname><given-names>P</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Aikal</surname><given-names>D</given-names></name><name><surname>Cai</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Impaired retrograde transport of axonal autophagosomes contributes to autophagic stress in Alzheimer’s disease neurons</article-title><source>eLife</source><volume>6</volume><elocation-id>e21776</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.21776</pub-id><pub-id pub-id-type="pmid">28085665</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility</article-title><source>Cell</source><volume>136</volume><fpage>163</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.11.046</pub-id><pub-id pub-id-type="pmid">19135897</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Winter</surname><given-names>D</given-names></name><name><surname>Ashrafi</surname><given-names>G</given-names></name><name><surname>Schlehe</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>YL</given-names></name><name><surname>Selkoe</surname><given-names>D</given-names></name><name><surname>Rice</surname><given-names>S</given-names></name><name><surname>Steen</surname><given-names>J</given-names></name><name><surname>LaVoie</surname><given-names>MJ</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>PINK1 and parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility</article-title><source>Cell</source><volume>147</volume><fpage>893</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.018</pub-id><pub-id pub-id-type="pmid">22078885</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Papadopulos</surname><given-names>A</given-names></name><name><surname>Harper</surname><given-names>CB</given-names></name><name><surname>Mavlyutov</surname><given-names>TA</given-names></name><name><surname>Niranjan</surname><given-names>D</given-names></name><name><surname>Glass</surname><given-names>NR</given-names></name><name><surname>Cooper-White</surname><given-names>JJ</given-names></name><name><surname>Sibarita</surname><given-names>JB</given-names></name><name><surname>Choquet</surname><given-names>D</given-names></name><name><surname>Davletov</surname><given-names>B</given-names></name><name><surname>Meunier</surname><given-names>FA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type A</article-title><source>The Journal of Neuroscience</source><volume>35</volume><fpage>6179</fpage><lpage>6194</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3757-14.2015</pub-id><pub-id pub-id-type="pmid">25878289</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lou</surname><given-names>N</given-names></name><name><surname>Eberhardt</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Kusk</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Förstera</surname><given-names>B</given-names></name><name><surname>Peng</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Ladrón-de-Guevara</surname><given-names>A</given-names></name><name><surname>Delle</surname><given-names>C</given-names></name><name><surname>Sigurdsson</surname><given-names>B</given-names></name><name><surname>Xavier</surname><given-names>ALR</given-names></name><name><surname>Ertürk</surname><given-names>A</given-names></name><name><surname>Libby</surname><given-names>RT</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Thrane</surname><given-names>AS</given-names></name><name><surname>Nedergaard</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An ocular glymphatic clearance system removes β-amyloid from the rodent eye</article-title><source>Science Translational Medicine</source><volume>12</volume><elocation-id>eaaw3210</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aaw3210</pub-id><pub-id pub-id-type="pmid">32213628</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Arnold</surname><given-names>ML</given-names></name><name><surname>Smart</surname><given-names>AJ</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Androwski</surname><given-names>RJ</given-names></name><name><surname>Morera</surname><given-names>A</given-names></name><name><surname>Nguyen</surname><given-names>KC</given-names></name><name><surname>Schweinsberg</surname><given-names>PJ</given-names></name><name><surname>Bai</surname><given-names>G</given-names></name><name><surname>Cooper</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>DH</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Large vesicle estrusions from <italic>C. elegans</italic> neurons are consumed and stimulated by glial-like phagocytosis activity of the neighboring cell</article-title><source>eLife</source><volume>01</volume><elocation-id>e82227</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.82227</pub-id><pub-id pub-id-type="pmid">36861960</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>FL</given-names></name><name><surname>Mills</surname><given-names>EA</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>DF</given-names></name><name><surname>Marsh-Armstrong</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cell type-specific translational profiling in the <italic>Xenopus laevis</italic> retina</article-title><source>Developmental Dynamics</source><volume>241</volume><fpage>1960</fpage><lpage>1972</lpage><pub-id pub-id-type="doi">10.1002/dvdy.23880</pub-id><pub-id pub-id-type="pmid">23074098</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss-Sadan</surname><given-names>T</given-names></name><name><surname>Maimoun</surname><given-names>D</given-names></name><name><surname>Oelschlagel</surname><given-names>D</given-names></name><name><surname>Kaschani</surname><given-names>F</given-names></name><name><surname>Misiak</surname><given-names>D</given-names></name><name><surname>Gaikwad</surname><given-names>H</given-names></name><name><surname>Ben-Nun</surname><given-names>Y</given-names></name><name><surname>Merquiol</surname><given-names>E</given-names></name><name><surname>Anaki</surname><given-names>A</given-names></name><name><surname>Tsvirkun</surname><given-names>D</given-names></name><name><surname>Kaiser</surname><given-names>M</given-names></name><name><surname>Michl</surname><given-names>P</given-names></name><name><surname>Gotsman</surname><given-names>I</given-names></name><name><surname>Blum</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cathepsins drive anti-inflammatory activity by regulating autophagy and mitochondrial dynamics in macrophage foam cells</article-title><source>Cellular Physiology and Biochemistry</source><volume>53</volume><fpage>550</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.33594/000000157</pub-id><pub-id pub-id-type="pmid">31529928</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>P</given-names></name><name><surname>Farhan</surname><given-names>H</given-names></name><name><surname>McEwan</surname><given-names>DG</given-names></name><name><surname>Wagner</surname><given-names>S</given-names></name><name><surname>Rogov</surname><given-names>VV</given-names></name><name><surname>Brady</surname><given-names>NR</given-names></name><name><surname>Richter</surname><given-names>B</given-names></name><name><surname>Korac</surname><given-names>J</given-names></name><name><surname>Waidmann</surname><given-names>O</given-names></name><name><surname>Choudhary</surname><given-names>C</given-names></name><name><surname>Dötsch</surname><given-names>V</given-names></name><name><surname>Bumann</surname><given-names>D</given-names></name><name><surname>Dikic</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth</article-title><source>Science</source><volume>333</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1126/science.1205405</pub-id><pub-id pub-id-type="pmid">21617041</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>YC</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation</article-title><source>PNAS</source><volume>111</volume><elocation-id>e52111</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.1405752111</pub-id><pub-id pub-id-type="pmid">25294927</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>YC</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>1293</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1870-13.2014</pub-id><pub-id pub-id-type="pmid">24453320</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Klionsky</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Autophagosome formation: core machinery and adaptations</article-title><source>Nature Cell Biology</source><volume>9</volume><fpage>1102</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1038/ncb1007-1102</pub-id><pub-id pub-id-type="pmid">17909521</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youle</surname><given-names>RJ</given-names></name><name><surname>Narendra</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mechanisms of mitophagy</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>12</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/nrm3028</pub-id><pub-id pub-id-type="pmid">21179058</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>DY</given-names></name><name><surname>Cringle</surname><given-names>SJ</given-names></name><name><surname>Balaratnasingam</surname><given-names>C</given-names></name><name><surname>Morgan</surname><given-names>WH</given-names></name><name><surname>Yu</surname><given-names>PK</given-names></name><name><surname>Su</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Retinal ganglion cells: Energetics, compartmentation, axonal transport, cytoskeletons and vulnerability</article-title><source>Progress in Retinal and Eye Research</source><volume>36</volume><fpage>217</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2013.07.001</pub-id><pub-id pub-id-type="pmid">23891817</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of neuronal autophagy in axon: implication of autophagy in axonal function and dysfunction/degeneration</article-title><source>Autophagy</source><volume>3</volume><fpage>139</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.4161/auto.3602</pub-id><pub-id pub-id-type="pmid">17204855</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Oglesby</surname><given-names>E</given-names></name><name><surname>Marsh-Armstrong</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title><italic>Xenopus laevis</italic> P23H rhodopsin transgene causes rod photoreceptor degeneration that is more severe in the ventral retina and is modulated by light</article-title><source>Experimental Eye Research</source><volume>86</volume><fpage>612</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2008.01.005</pub-id><pub-id pub-id-type="pmid">18291367</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Ahsan</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>F</given-names></name><name><surname>Qin</surname><given-names>Z-H</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Somatic autophagy of axonal mitochondria in ischemic neurons</article-title><source>The Journal of Cell Biology</source><volume>218</volume><fpage>1891</fpage><lpage>1907</lpage><pub-id pub-id-type="doi">10.1083/jcb.201804101</pub-id><pub-id pub-id-type="pmid">30979799</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Pappas</surname><given-names>AC</given-names></name><name><surname>Seifert</surname><given-names>P</given-names></name><name><surname>Savol</surname><given-names>A</given-names></name><name><surname>Sadreyev</surname><given-names>RI</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Jakobs</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Astrocytes in the optic nerve are heterogeneous in their reactivity to glaucomatous injury</article-title><source>Cells</source><volume>12</volume><elocation-id>2131</elocation-id><pub-id pub-id-type="doi">10.3390/cells12172131</pub-id><pub-id pub-id-type="pmid">37681863</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103844.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bernstein</surname><given-names>Audrey M</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040kfrw16</institution-id><institution>State University of New York Upstate Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Syracuse</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>This work describes the effect of Optineurin (OPTN) mutations in the transcellular degradation of retinal ganglion cell mitochondria by astrocytes in the Optic Nerve, a process termed, &quot;transcellular degradation of mitochondria&quot;. The authors perform compelling live imaging studies of the <italic>Xenopus laevis</italic> optic nerve to track neuronal mitochondrial movement and expulsion in an intact nervous system. These important findings demonstrate that Optineurin mutations that are associated with disease increase the stationary pool of mitochondria resulting in increased rates of transcellular degradation.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103844.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bernstein</surname><given-names>Audrey M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040kfrw16</institution-id><institution>State University of New York Upstate Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Syracuse</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103844.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Evidence, reproducibility and clarity (Required)):</p><p>Glaucoma-associated optineurin mutations increase transmitophagy in vertebrate optic nerve.</p><p>Summary</p><p>In Jeong et al., the authors perform live imaging of the <italic>X. laevis</italic> optic nerve to track neuronal mitochondrial movement and expulsion in an intact nervous system. The authors observe similar mitochondrial dynamics in vivo as previously described in other systems. They find that stationary mitochondria are more likely to be associated with OPTN, suggestive of mitochondria undergoing mitophagy. Forced expression of OPTN mutations results in a larger pool of stationary mitochondria that colocalize withLC3B, and OPTN. Finally, the authors argue that extra-axonal mitochondria are observed more frequently in OPTN mutants, suggesting that mutations in OPTN that are associated with disease can lead to an increase in the expulsion of mitochondria through exopher-like structures.</p><p>Major Findings and impact:</p><list list-type="bullet" id="list2"><list-item><p>The authors establish that mitochondria dynamics can be tracked in the <italic>X. laevis</italic> optic nerve.</p></list-item><list-item><p>OPTN mutations increase the stationary pool of mitochondria and likely result in increased rates of mitophagy.</p></list-item><list-item><p>Exopher-like structures containing mitochondria and LC3 can be expelled from the optic nerve and increase in the presence of OPTN mutations. These structures were observed in a living system and have interesting implications in the context of disease.</p></list-item></list><p>Concerns:</p><list list-type="bullet" id="list3"><list-item><p>The authors state in their results that the secreted blebs are exophers. While these initial observations are consistent with exophers, additional data are needed to strengthen this claim. For example: what are the sizes of secreted vesicles? Do all express LC3? How frequently do these occur? From where are they expelling? Alternatively, the discussion of exophers could be moved to the discussion.</p></list-item></list></disp-quote><p>We agree that calling the axon shedding intermediates “exophers” was an overreach on our part. While we believe that in all probability time will demonstrate this to be the case, reviewers are correct in stating that putting our work in the context of exophers is best left to the discussion. We have removed all mention of exophers from the results and graphical abstract and now use the term only once in the discussion. We do provide detail as to the frequency of the structures, what fraction contain mitochondria, and morphological parameters of the contained mitochondria. And while all of these new data support them being exophers, the point remains that the use of the nomenclature “exopher” in the Results section was inappropriate.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list4"><list-item><p>Quantifications in sparse labeling experiments seem quite surprising and concerns related to these findings should be addressed. As the authors used LC3b expression to represent axonal volume, the authors should demonstrate that this is the case using an axonal fill or membrane marker in both the wt and E50K conditions. This is important as it is unclear whether LC3b expression is consistent between the wild type and the E50K conditions. Lower expression of LC3b in E50K could account for the large changes in axonal width that seem to be observed and could confound the measured amount of expelled mitochondria.</p></list-item></list></disp-quote><p>We agree that using EGFP-LC3b as a “cell fill” was problematic in a situation where the interventions likely perturb autophagy/mitophagy and therefore might have also perturbed LC3b. We do provide some axon width and LC3b-EGFP intensity data for a partial dataset that had been imaged side-by-side, showing that expression of LC3b is not different in the two conditions. We also provide independent measures of extraaxonal mitochondria based on a membrane-GFP reporter. While in principle there would be value to repeat the studies of Wt vs. E50K in the context of the membrane-GFP reporter, these experiments would involve new constructs and new breedings, and would likely take months to years to complete.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list5"><list-item><p>Could large amounts of exogenous mitochondria in explant experiments be from cells that died during the plantation?</p></list-item></list></disp-quote><p>The concern that some of the exogenous mitochondria signal might derive from degenerating axons is one that we worry much about, and not only in the transplantation experiments. In our sparse labeling experiments we do occasionally see axons undergoing Wallerian degeneration, but it is rare and does not appear to be more common in the expression of the mutated OPTN, at least not at the stage after transgene expression that the analyses were performed. We do provide new data that expression of E50K OPTN does not compromise vision at the time that experiments were carried out, ruling out that extra-axonal mitochondria are the result of large-scale degeneration. However, from other data we know that axon loss would likely need to be very extensive to manifest itself in functional vision loss in our behavioral assay, so milder axon loss contributing some noise to the measures cannot be excluded. But, the point raised is heard, and now we include a sentence in the discussion acknowledging that some of the signal outside of axons could have been due to degenerating axons, but still contend that our documentation of shedding intermediates support the view that many of the axonal mitochondria outside of axons were shed from otherwise intact axons.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list6"><list-item><p>In OPTN/MITO/LC3b trafficking experiments, does flux/number of events change? Representative kymograph in Figure 2D seems to show far more OPTN-positive mitochondria which is opposite of what is shown in Figure 2C.</p></list-item></list></disp-quote><p>Multiple reviewers rightfully point out that we did not carry out the flux experiments which would be necessary to make definitive statements regarding the amount of mitophagy. New experiments show that inhibiting lysosomal activity through chloroquine does increase the amount of astrocytic autophagosomes not yet acidified as expected, and that they contain axonal mitochondria signal, supporting the idea that astrocytes are involved in the degradation of axonal mitochondria. However, they did not show changes in the amount of stopped mitochondria, supporting the view that the co-localization of OPTN and mitochondria in axons is not conventional autophagy. This is a very important point that affects the interpretation of our results, and we thank reviewers for suggesting this experiment.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list7"><list-item><p>Demonstrate that axonal width measured with LC3B is representative of axonal fill/membrane marker in wt and E50K. Axonal area appears to change, is this accurate? This appears to be the case for both figure 3 and figure 4.</p></list-item></list></disp-quote><p>Addressed above.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list8"><list-item><p>Raw images in addition to the reconstruction would be beneficial.</p></list-item></list></disp-quote><p>Now include raw images beside the reconstruction at the first use of reconstructions.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list9"><list-item><p>Further characterization of exopher-like structures.</p></list-item></list></disp-quote><p>Addressed above.</p><disp-quote content-type="editor-comment"><p>Referees cross-commenting</p><p>I agree with the concerns of the other reviewers, and perhaps was over-optimistic about a timeline for revision. However, I do think the work is worth the effort, and I hope to see a revised manuscript published somewhere, as these observations are novel</p><p>Reviewer #1 (Significance (Required)):</p><p>This work reports potentially novel biology, and thus will be of interest to the field. The strength of the study is that it is an initial description of this biology, rather than a complete analysis. The work raises many more questions than it answers, and much further work on this topic is required to support these initial findings, but the manuscript will likely be of interest to many. Revisions are required to improve the rigor and clarity of the work, but following these revisions we recommend publication to facilitate follow-up work.</p></disp-quote><p>Fully agree that our study raises far more questions than it answers. Believe that the revisions made to address reviewer comments go a long way to improve rigor and clarity of the work. We hope that the reviewers agree and deem the changes sufficient.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Evidence, reproducibility and clarity (Required)):</p><p>Summary:</p><p>This article studied transmitophagy in Xenopus optic nerves in the context of overexpressing glaucoma-associated optineurin mutations. Using a series of labeling, imaging and transplantation techniques, the authors found that overexpressing mutated optineurins stops mitochondria movements and potentially induces transmitophagy, and that astrocytes are responsible for taking up the extra-axonal mitochondria. Below are my comments on this article.</p><p>Major comments:</p><p>1. Identifying extra-axonal mitochondria is key to this research. In Figure 3, the authors used EGFP-LC3B as a marker for RGC boundaries. However, it is unconvincing how perfect LC3B is as a cell membrane marker. Particularly in the case of OPTN E50K OE, it seems that the optic nerve is thinner than the WT condition, which makes the quantification of extra-axonal OPTN less convincing. The authors should detect extra-axonal mitochondria with an RGC membrane marker or cytosolic marker. In addition, in Figure 3, the extra-axonal mitochondria seem to localize mostly on the dorsal surface. Why is there such a polarity?</p></disp-quote><p>As stated above, we acknowledge that the use of LC3b as both an autophagosome marker and a cell fill was somewhat problematic and now provide additional experiments ruling out that the LC3b expression or axon thickness in our sparse axon labeling experiments, or that E50K might affect the thickness of the optic nerve. In addition, we also provide additional new data using a <italic>bona</italic> fide membrane marker together a transgenic labeling or RGC mitochondria that also shows under the “baseline state” extensive mitochondria signal outside the axons on the surface of the optic nerve (New Figure 6A and new Suppl Figure 3D). All the new data are consistent with the previous data and support the view that using LC3b potentially could have been problematic, for the reasons reviewers state, but in practice it was not.</p><p>The reviewer observes that the E50K optic nerve appears thinner--this observation is not a consistent difference in optic nerves across the experimental groups. The images we show are always near the mean values for the quantitative results presented, and we rather not include prettier nerves that are not representative of the whole datasets.</p><p>As for why the extra-axonal mitochondria localize mostly to the dorsal surface, it remains undetermined.</p><p>There are dorsoventral differences in the optic nerve established during development, as developmental Sonic hedgehog signaling emanating from the midline appears to affect dorsoventral aspects of the optic nerve differentially. Early axon loss in humans and some models of glaucoma do show a dorsal bias, and there may be optic nerve lymphatic structure reported in mice that also may be preferentially dorsal. However, it is not known whether any of these observations are connected, so we did not want to speculate beyond what the data say. We do now explicitly mention the dorsoventral difference in the discussion, and state why we think it may be worth further study.</p><disp-quote content-type="editor-comment"><p>2. The experiment in Figure 5 is very important as it gives direct evidence of transmitophagy. However, one caveat is that the mitotracker injection is done after the transplantation. If in rare cases the dye is leaky after injection and is taken up by astrocytes directly, then the conclusion that mitochondria from RGCs are phagocytosed by astrocytes will be flawed. The authors should either use a transgene in the donor to label mitochondria or inject mitotracker into the donor before the transplantation and repeat the experiments. In addition, in Figure 5E, what is the large membranous structure inside the highlighted astrocyte? Is it associated with phagocytosis?</p></disp-quote><p>We fully agree that MitoTracker is an imperfect tool, both for the reason stated here that the dye may get into the astrocytes directly (or may label astrocyte mitochondria after it is released from degrading RGC mitochondria), and, also as stated by reviewer 3, that it requires healthy mitochondria for labeling. For this reason, we have added new datasets that rely on RGC mitochondria labeling not by Mitotracker but through a genetic reporter. As to identity of the conspicuous structure shown inside the astrocytes, it remains an open question, and we are avidly pursuing what astrocytic organelles are involved through additional transgenic reporters and correlated-light-EM studies, but those are complicated experiments that are beyond the scope of the current manuscript.</p><disp-quote content-type="editor-comment"><p>3. This research is entirely based on overexpression of OPTN. Since overexpressing WT OPTN does seem to affect mito trafficking (Figure S2G, and the description in the manuscript is often inconsistent with this result), it is unclear what the increased stalled mitochondria really mean when overexpressing mutated OPTN. Similarly, the authors examined extra-axonal mitochondria in Figures 3 and 4 all in overexpressing conditions, and made the connection that increased stalled mitochondria lead to transmitophagy. However, this conclusion will be better supported by using mutant animals rather than overexpression. The authors should consider using OPTN mutant Xenopus if available or using CRISPR to introduce the specific mutations and repeat mitochondria trafficking and transmitophagy.</p></disp-quote><p>We thank this reviewer by pointing out an important detail that we failed to highlight, namely that transgenic overexpression of Wt OPTN (and/or Wt LC3B) does have a small but significant effect on mitochondria trafficking. Interestingly, it is affecting just the speed of retrogradely transported mitochondria, which based on the elegant work of Holzbaur and colleagues, include mitochondria destined for degradation. So, we now acknowledge more explicitly that, since our studies involve expression of OPTN and LC3b transgenes (fluorophore tagged human genes, no less), that some caution should be exercised in not overinterpreting the results. Nonetheless, since we show that expression of Wt OPTN behaves similarly to expression of a mitochondria reporter (Tom20-mCherry) in not affecting either stopped mitochondria or extra-axonal mitochondria, we believe that our results still stand. Nonetheless, we now make mention of the effect Wt OPTN on retrograde mitochondria movement. We have embarked on OPTN loss-of-function studies and have some founder animals carrying CRISPR-generated mutations; however, these experiments will take additional time, and based on the results in mammals may or may not show any measurable effects in our assays, not only because of possible redundancy by the other damaged mitochondria adaptors that we mention in the introduction, but also because the mutations that affect the shedding process (as well as cause glaucoma) are thought to be gain-of-function mutations. However, we decided not to dwell on these complexities in the discussion, as the discussion was previously quite extensive and now is even more so with the added discussion on how our studies relate to those of exophers.</p><disp-quote content-type="editor-comment"><p>4. On Page 12, the authors claim that even overexpressing WT OPTN causes extra-axonal mitochondria in the optic nerve. However, there is no control condition without OE to support this conclusion. It is thus unclear to what extent extra-axonal mitochondria occur at baseline and how many extra-axonal mitochondria can be induced by overexpression. The authors should include, in Figure 3 and 4, controls without overexpression.</p></disp-quote><p>We acknowledge that our language was confusing and somewhat misleading on this point. With the caveat mentioned above that WT OPTN expression does perturb the system somewhat (by increasing the speed of mitochondria retrograde transport, perhaps by increasing the proportion of retrograde moving mitochondria tagged for degradation), we still contend that the state observed after WT OPTN expression is close to the “baseline” state. In support of that, in the new data included in response to the LC3b concern, we observe plentiful shedding events in the absence of any OPTN or LC3b transgenes. Indeed, what may be the most surprising finding of our studies is that in the absence of any significant perturbation of OPTN, there is already a large fraction of axonal mitochondria that are outside of axons and inside of astrocytes, which is consistent with what we previously observed in the optic nerve head of mice; however, the current studies provide much more rigorous quantification of the process and live imaging of intermediates, but also provide for an intervention that increases the process. While there are many more questions to answer, we do believe our studies contribute mechanistic insights.</p><disp-quote content-type="editor-comment"><p>5. A technical question regarding kymographs: Based on Figure 2C, it looks that OPTN and LC3B labeling are pretty diffuse in axons and this makes sense since they may only be associated with damaged mitos. But this raises a question about how accurate the kymograph assay is. It may significantly underestimate the fraction of OPTN/LC3B that is stationary since they appeared diffusedon the kymograph. This may explain why the percentage of stationary OPTN/LC3B is so small when the authors OE WT OPTN in Figure 2E and 2E', compared to the percentage of moving mitochondria shown in Figure 1E.</p></disp-quote><p>We fully agree that the kymograph studies likely underestimate the amounts of stationary mitochondria for the reasons stated. However, we interpret the discrepancy between Figure 1E and 2E and 2E’ differently. We believe that the value of stopped mitochondria in the sparse labeling experiments are actually more accurate, as the value of stopped mitochondria in the whole nerve experiments likely include mitochondria stopped within the axons, but also mitochondria recently shed either by those or nearby axons which are perceived to be in axons due to limitations of imaging resolution. In the discussion we now make very explicit that all the measures we provide need should be interpreted as estimates, as every experiment relies on assumptions and is subject to technical limitations.</p><disp-quote content-type="editor-comment"><p>Minor:</p><p>1. Figure 2E and 2E' do not agree with the text on page 7 and page 8. Not only F178A, but also H486R and D474N have no effect on OPTN trafficking. The authors should make their conclusions more accurate.</p></disp-quote><p>F178 was the only mutation that had no effect on either OPTN or LC3b in either F<sub>0</sub> or F1 experiments. However, we agree that our language should have been clearer, and now we have made our description of the results (and conclusions) more accurate.</p><disp-quote content-type="editor-comment"><p>2. Figure S2E-F: why does OE of mutated OPTN in F1s but not in F0s reduce trafficking speed compared to WT?</p></disp-quote><p>We do not know the reason for this discrepancy. Though it does not wholly agree with the rest of the story, we felt it important to include all relevant data, not only that which perfectly fit our interpretation. One possible reason may be that the F1 data derives from a single integration event, which is the reason why we trust more the F<sub>0</sub> data that derive from multiple integrations, in what are essentially outbred animals, which is the reason we present the F<sub>0</sub> data as the primary results where possible.</p><disp-quote content-type="editor-comment"><p>3. In movie 5, fusion of exopher with other structures is not clear and also the GFP signal does not disappear, which is in contrast to the statement in the text that the GFP signal is quenched in acidified environment. To confirm that LC3B leaves RGC axons in exophers, the authors should consider switching the fluorophores and examine LC3B localization during exopher formation.</p></disp-quote><p>This too is a valid point, and we have amended our description of these results. While swapping fluorophores between OPTN and LC3b is a highly worthy experiment, for technical reasons it likely would take many months to carry out just because of how involved it is to make the relevant constructs (recombineering details provided in the methods section).</p><disp-quote content-type="editor-comment"><p>4. In figure 6, to better show exopher formation and the pinching-off step, the authors should consider labeling the membrane and mitochondria instead of using the LC3B and OPTN marker.</p></disp-quote><p>This arguably was the biggest weakness of our initial submission, and now provide new experiments using a <italic>bona fide</italic> membrane marker. We have not yet captured a pinching-off event with these better reporters, but that is not surprising given how rare they are, which we now quantify. Indeed, a membrane reporter and a mitochondria transgene in sparsely labeled axons are the ideal tool for figuring out the frequency of these structures and what fraction contain mitochondria, data which we now provide.</p><disp-quote content-type="editor-comment"><p>Referees cross-commenting</p><p>Generally agree with the criticisms voiced by the other reviewers; in aggregate the reviews indicate the manuscript needs more than just a quick fix.</p><p>Reviewer #2 (Significance (Required)):</p><p>Previous literature has already described the transmitophagy process in the optic nerve. The significance of this paper lies in the observation that overexpressing glaucoma-associated OPTN mutants can induce increased transmitophagy through astrocytes, which points to a potential role of OPTN in glaucoma. A highlight of this paper is the use of correlated light SBEM to directly show transmitophagy in astrocytes. However, the significance of this paper may be limited for the following reasons: 1. everything is based on overexpression of mutated OPTN, which makes it hard to translate the results to real disease conditions; 2. The consequence of increased transmitophagy on RGC survival or visual functions is unclear.</p></disp-quote><p>While we agree that much of the paper is based on OPTN overexpression, we did have experiments and now provide more that were not based on OPTN overexpression. Some of these still involve expression of a different transgene (Tom20-mCherry) that might in principle perturb the system, though we show that expression of Tom20-mCherry does not affect mitochondria movement parameters as measured by Mitotracker. As to “the consequence of increased transmitophagy”, we do now provide data showing that there is no vision loss suggestive of axon loss or severe dysfunction at the time that the imaging studies were carried out. Whether longer term expression of these OPTN transgenes lead to axon degeneration and visual dysfunction are studies that are ongoing, but those studies involve extensive characterizations and controls that are beyond what could be included in this study.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Evidence, reproducibility and clarity (Required)):</p><p>Summary</p><p>In this work, Jeong et al. describe the effect of Optineurin (OPTN) mutations in the transcellular degradation of retinal ganglion cell (RGC) mitochondria by astrocytes at the Optic Nerve (ON), a process previously described this group and referred as &quot;transmitophagy&quot; (Davis et al. 2014). Here, authors use <italic>Xenopus laevis</italic> animal model to image the optic nerve of animals carrying different OPTN mutations associated to disease or with compromised function and explore its effect in mitochondria dynamics at the RGC axons. They find that OPTN mutants lead to increased stationary mitochondria in the nerve and affect their co-localization with mitophagy-related markers, suggesting alterations in this pathway. Finally, they found that mitochondria colocalizing with OPTN can be found in the periphery of the ON under different conditions and this is particularly increased in glaucoma-associated E50K mutation. This extracellular mitochondria are transferred in vesicles to astrocytes, as they previously described in mice (Davis 2014), where they are presumably degraded.</p><p>Major comments:</p><list list-type="bullet" id="list10"><list-item><p>OPTN levels at a given time point cannot be used as readout for mitophagy level/flux. Both OPTN and LC3b are degraded upon fusion with acidic compartment (i.e. lysosomes, PMID: 33783320, 33634751) and that is the reason why the field of autophagy /mitophagy blocks lysosomal activity to measure autophagy/mitophagy flux (PMID: 33634751). In this document, authors claim that there is low levels of mitophagy in RGC axons at baseline and increased levels of mitophagy in glaucoma associated perturbations just based on increased presence of OPTN+ mitochondria in this condition. This could be also interpreted as an accumulation of nondegraded defective mitochondria due to a mitophagy block in neurons carrying the glaucoma associated mutation, which is the opposite of what they propose. If authors want to evaluate mitophagy levels in this system, mitophagy/autophagy flux experiments should be performed.</p></list-item></list></disp-quote><p>In response to reviewers, we do now include “lysosome inhibition” experiment, using chloroquine at doses modestly above those used in aquaculture as an anti-parasitic. After testing various chemical means to inhibit lysosome activity, it was the only one that did not adversely affect the animals. We know the chloroquine intervention works because we see the expected increase in autophagosomes using the standard LC3btandem reporter, and in those unacidified astrocytic autophagosomes we do indeed find axonal mitochondria signal. However, since the amount of mitochondria signal there is small relative to the total amount of axonal mitochondria in the astrocytes, we do not feel it would be appropriate to make mechanistic claims, for example claiming this to be related to LC3b associated phagocytosis; much more work would be needed to make that claim. However, we were surprised to find no alteration in either stopped mitochondria in axons or axonal mitochondria material within the astrocytes. There are technical reasons why this result might be difficult to interpret, but now having done it (as we should have before), we are even more careful in describing the process as transcellular degradation rather than transmitophagy. We elaborate further on this point in the next response.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list11"><list-item><p>I find inappropriate the use of the term &quot;transmitophagy&quot;. Although this term transmits very well the message that the authors try to strength, the term &quot;mitophagy&quot; refers to the specific elimination of mitochondria through autophagy (PMID: 21179058). There are many reasons why I think that &quot;transmitophagy&quot; is not adequate to describe this phenomena but I will just refer to these three: First, authors do not provide data showing that this mechanism is specific for mitochondria as they have never checked for the presence of other type of cargo in the vesicles produced by RGCs. If these are related to exophers as they suggest in the document, is very probable that they contain other type of cargo; Second, if the final destiny for those particles is the acidic compartment of astrocytes, this process may have nothing to do with autophagy/mitophagy and just share some molecular mediators with those pathways; Third, they should explore if other canonical mitophagy molecular mediators (i.e. Parkin/Pink) are regulating the production or the mitochondria recruitment to this extracellular particles.</p></list-item></list></disp-quote><p>We too struggle with our own “transmitophagy” term, for the very reasons stated. To address this concern, we now refer to the process as “transcellular degradation of mitochondria”, which is how we described it initially in mice as well. We do present new data that show that while the majority of axonal outpocketings contain mitochondria, not all do. This suggests that the others may contain other cargo, which supports the view that what we are dealing with in axons are indeed exophers. And yet, since what we measure is mitochondria, we think most appropriate to describe the process narrowly and not extrapolate to other types of exophers. We agree that what we originally discovered in mice and now live image and perturb in frog, may not be “autophagy” according to the strict definition of the term, but rather a process that uses some of the same molecular machinery, which given the evolutionary link between autophagy and phagocytosis that should be no surprise. Terminology can be tricky, and we thank the reviewer for calling us out on this point. We now use the term “transmitophagy” only once in the Discussion section making the link between our work and the emerging field of exopher biology, and use that occasion to elaborate the point that the more descriptive term “transcellular degradation of mitochondria” is more appropriate in our case.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list12"><list-item><p>In several experiments, authors use Mitotracker instead of genetic tools to quantify the amount of mitochondria co-localizing with OPTN (Figure 2, Figure 3) or being transferred to astrocytes (Figure 4). A problem here is that Mitotracker needs the mitochondria to be active at the time of injection in order to label them (PMID: 21807856) and it has a clear effect in mitochondria dynamics in their setting, as pointed by the authors. Since most mitochondria transferred to astrocytes would be presumably damaged and not able to import Mitotracker, I am concern about how this is affecting their quantifications and the conclusions.</p></list-item></list></disp-quote><p>We agree. The use of Mitotracker to label the RGC mitochondria can be problematic for the reasons stated by reviewers 1 and 3. Indeed, our opinion is that many of the studies out there that claim to demonstrate transfer of mitochondria between cells likely are just showing the transfer of the dye rather than the mitochondria. While the previous submission included a number of controls to address this concern, we now provide multiple new experiments that measure the transfer of mitochondria through a transgene rather than Mitotracker. The provided experiments use a new Tom20-mCherry transgene which is highly specific to mitochondria due to the use of an SOD2 UTR. We have similar data using RGC-expressed Mito-mCherry and Mito-EGFP-mCherry (using the commonly used Cox8 mitochondria matrix targeting sequence); we do not include such data because we find the provided data sufficiently compelling, and the story is already sufficiently long and complicated.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list13"><list-item><p>Some conclusions are based on single images with no quantifications or statistics. This is the case for: Page 6 &quot;Most of the mCherry and Mitotracker objects colocalized with each other both in the merged images (Figure S1C) and kymographs (Figure S1D), indicating that the mitochondria-targeted transgene and Mitotracker similarly label the RGC axonal mitochondria&quot;.</p></list-item></list></disp-quote><p>That is a fair comment. After reanalyzing the original dataset used, it would be very difficult to quantify that statement, largely because the Tom20-mCherry expression was relatively weak in those particular animals. We are confident that we could generate a new dataset to provide support for this statement, but instead chose to just provide side-by-side movies of mitochondria labeled by Mitotracker or the Tom20-mCherry transgenes, which we believe is far more compelling than any quantification we could provide.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list14"><list-item><p>Page 8 &quot;In the nerves labeled by Mitotracker, visual inspection of the raw images (Figure 2C) and the derived kymographs (Figure 2D) showed that OPTN and the Mitotracker labeled mitochondria often co-localized, particularly in the stopped populations, and more so in the animals expressing E50K OPTN, further suggesting that at least a fraction of the stopped LC3b, OPTN and mitochondria might represent mitophagy occurring in the axons&quot;.</p></list-item></list></disp-quote><p>While we have made a minor change to this sentence, we feel that it is appropriate given that it serves just as a justification to carry out the quantitative studies that follow. We would not have quantified the process had it not been obvious to the eye. However, we do not interpret the results as supporting that mitophagy occurs in axons, for the reasons explained above.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list15"><list-item><p>Page 14 &quot;We also observed similar axonal dystrophies and exopher-like structures in E50K OPTN under similar imaging settings, but with 2-min intervals and additional Mitotracker labeling (Video 6), demonstrating that these structures not only contain OPTN but also mitochondria or mitochondria remnants&quot;. Image in video is not clear and there is not quantification for OPTN or OPTN+ mitochondria.</p></list-item></list></disp-quote><p>We have removed Video 6.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list16"><list-item><p>In Figures showing the reconstruction of OPTN+ mitochondria outside nerve (Figure 3 and Figure 4), those seem to be present only in one lateral of the nerve. Is this process polarized in any way (i.e. faced to astrocytes) or is the result of a technical issue (i.e. difference in laser penetration for blue vs Yellow lasers)? I think it will be important to include this in the discussion.</p></list-item></list></disp-quote><p>This was also pointed out by reviewer 1, and we agree that it is worth including in the discussion, which we now do. While we do not believe it to be a light penetration issue (based on fluorescence intensities and apparent spatial resolution), we also do not yet have an explanation. Having studied dorsoventral differences in the visual pathway both during my graduate and post-doctoral years, I am very interested in this asymmetry, and we have some theories that might explain it, mentioned above. The asymmetry is obvious and thus we think it would have been inappropriate not to show, but it also be inappropriate to be overly speculative.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list17"><list-item><p>In Pag.13 authors claim &quot;OPTN and mitochondria leave RGC axons in the form of exophers&quot;. After &quot;exophers&quot; were coined by the Driscoll lab in 2017, too few people has adopted this terminology and the molecular machinery involved in this process is still under research. It is clear that the particles described here share some similarities with exophers like size (in the range of microns) and cargo (mitochondria), but you have not demonstrated if they share the same origin or are part of the same phenomena. For that reason, I recommend to be more cautious with this statement and point these limitations in the discussion. Additionally, since Exophers are not a consensus or well defined particles, authors should include an introductory paragraph at the beginning of this section for readers to understand what they are talking about.</p></list-item></list></disp-quote><p>We wholly agree with all points. We now have moved all mention of exophers to just the discussion.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list18"><list-item><p>Exophers described by Monica Driscoll and Andres Hidalgo laboratories are presented as &quot;garbage bags&quot; that help cells to stay fit through elimination of unwanted material. If the extracellular vesicles presented here are part of the same mechanism and potentially beneficial for the RGCs, why are they increased in OPTN mutants? Is it part of RGCs response to a proteomic stress generated by malfunctioning OPTN? I think that is critical to understand this to figure out the relevance of your findings.</p></list-item></list></disp-quote><p>Our personal opinion is that the OPTN mutants most likely lead to stress focally in the axons, thus triggering exopher generation. We are carrying additional experiments to determine whether too much exopher generation or their insufficient degradation by astrocytes might be deleterious (by causing inflammation). However, those are big stories that would not stand on their own were we not able to first rigorously demonstrate that certain OPTN mutants increase exopher generation, which I believe our study demonstrates, albeit now without calling them exophers.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list19"><list-item><p>Related to Figure 5G, authors say &quot;The soma of the astrocytes were located at the optic nerve periphery but had processes that extended deep into the parenchyma&quot;. This is very interesting and opens the possibility that many mitochondria are directly transferred to astrocytes through that processes instead of the lateral of the nerve, meaning that your quantifications of &quot;transmitophagy&quot; may be underestimated.</p></list-item></list></disp-quote><p>We also agree that this. Our limited optical resolution, and limitations intrinsic to carrying out quantifications with Imaris software, are likely the main reasons for the discrepancy between the whole nerve and sparselabelled-axon estimates of how much axonal material is outside of axons. Our view is that most of the transcellular degradation occurs within fine astrocyte processes, and that only in the case of failure to degrade material in these fine processes that significant amounts accumulate in the cell body (optic nerve periphery), and that in the cell body additional or different degradative pathways are utilized. Experiments using various transgenes and correlated EM as well as perturbation experiments are ongoing attempting to firmly establish what organelles are used in processes versus soma. However, we believe that such studies are well beyond the scope of this manuscript..</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list20"><list-item><p>Reference to Figure S2G is missing.</p></list-item></list></disp-quote><p>Now mentioned twice. Thank you.</p><disp-quote content-type="editor-comment"><list list-type="bullet" id="list21"><list-item><p>I cannot find in Figure 5 E-I legends what are the cells/structures labelled in Green and Red.</p></list-item></list></disp-quote><p>Thank you.</p><disp-quote content-type="editor-comment"><p>Referees cross-commenting</p><p>In agreement with my colleagues, I think that a revision is needed to support some important points of the paper. The work is interesting and I think it deserves a chance for revision. Having that said, I am not familiar with the breeding and experimental times when working with Xenopus but, considering the amount of work requested, it may require more than 3 months to have the work done.</p><p>Reviewer #3 (Significance (Required)):</p><p>Until not very long ago, it was thought that mitochondria could not cross cell barriers. In recent years however, there has been an explosion in the number of works showing mitochondria transfer between different cell types in vivo. This may happen either as an organelle donation to improve energy production or as a quality control mechanism to get rid of damaged mitochondria, as it is the case in this work. The laboratory of Nicholas Marsh-Armstrong was pioneer in this field with a foundational work in 2014 where they show how RGC-derived mitochondria are captured and eliminated by astrocytes in mice (PMID: 24979790). This work was particularly relevant because it proposed for the first time that mitochondrial degradation can occur in RGC axons far from the cell soma, and surrogated in a different cell type, something that changed completely the view of how quality control is maintained in neurons and other cell types.</p><p>In the present study, Jeong and collaborators explore how Glaucoma-associated Optineurin mutations affect this process, which is of potential interest for the broad cell biologist community due to its possible implications in other tissues and cell types (OPTN is broadly expressed), but especially for those researchers interested in neurobiology, quality control mechanisms and mitochondria biology. Since some OPTN mutations studied here cause disease, they are also relevant for the clinic.</p><p>This work provides a thorough characterization of how relevant Optineurin mutations affect mitochondria dynamics in RGCs and their transference to astrocytes, as fairly claimed in the title. However, the mechanism by which they result in pathology is not either explored or carefully discussed, making this a descriptive work with no much conceptual insight. In addition, conclusions are often not unambiguously stated and the results part contains a lot of large sentences and unnecessary technical data that hinders reading and difficult the transmission of the key messages.</p><p>Even if it stands as a descriptive work, the physiological and clinical relevance of these findings is not clear.</p><p>There are some claims related with mitophagy activity that may require more sophisticated experiments (mitophagy flux with lysosomal inhibitors). Please see comments above. A critical point to understand the relevance of this work would be to demonstrate if alterations in transmitophagy are either causing or involved in the disease generated by these OPTN mutations in any way, or just a correlative phenomenon. To help authors contextualize my point of view, my field of expertise includes cell biology, imaging, quality control pathways, mitochondria biology and phagocytosis, among others. I am not familiar with <italic>Xenopus laevis</italic> genetics or the limitations to work with this animal model.</p></disp-quote><p>We appreciate both the complements and the critiques. To a fault, we rather undersell than oversell. We are actively pursuing the possibility that dysregulation of this process is disease causing, and not just for glaucoma. However, those studies will not stand without a strong foundation, which we believe this study provides.</p></body></sub-article></article>